.png)
COVID-19 Evidence Reviews
as of 10/4/22
= living review
= draft/preprint | A review with this mark was peer-reviewed, described systematic search and study selection, and included critical appraisal of primary studies.
 latest update date
 |
select |
|
|---|---|---|
|
9/28/22
|
Huang HB, Yao Y, Zhu YB, et al. | Front Med
Aim: To conduct an updated meta-analysis enrolling only COVID-19 patients in the ICU who received APP.
|
|
|
9/28/22
|
Mirmosayyeb O, Moases Ghaffary E, et al. | Can J Infect Dis Med Microbiol
Aim: To assess MG patients after the COVID-19 vaccination.
|
|
|
9/28/22
|
Foka FET, Manamela N, Mufamadi SM, et al. | Biomed Res Int
Aim: To highlight the specific attributes that make Azadirachta indica (neem plant) a suitable candidate for the biosynthesis of anti-SARS-CoV-2 nanoparticles.
|
|
|
9/28/22
|
Sharma A, Vats S, Gupta R, et al. | J Lifestyle Med
Aim: To analyse the overall certainty of evidence regarding the effectiveness of exercise treatment, as well as novel emerging chest rehabilitation approaches during COVID-19 outbreak. UPDATED
|
|
|
9/26/22
|
Saluja P, Amisha F, Gautam N, et al. | Vaccines
Aim: To analyze the clinical characteristics, therapeutic strategies, and outcomes of patients presenting with ITP after receiving COVID-19 vaccination.
|
|
|
9/26/22
|
Albanese A, Sormani MP, Gattorno G, et al. | Mult Scler Relat Disord
Aim: To review the evidence for estimating the severity of COVID-19 events, evaluated as mortality and hospitalization rate, among patients treated with cladribine. UPDATED
|
|
|
9/26/22
|
Patrizio A, Ferrari SM, Elia G, et al. | Vaccines
Aim: To report all the postvaccine cases of GD documented in the literature up to 31 July 2022, more than a year after the beginning of the immunization campaign, focusing on their main epidemiological and clinics features.
|
|
|
9/26/22
|
Kang L, Shang W, Gao P, et al. | Vaccines
Aim: To systematically evaluate the immunogenicity and safety of COVID-19 among PLWH. UPDATED
|
|
|
9/26/22
|
Ahmed A, Tanveer M, Shrestha S, et al. | Healthcare
Aim: To review the evidence on the interventions and impact of pharmacist-delivered services in managing COVID-19 patients. UPDATED
|
|
|
9/26/22
|
Zace D, La Gatta E, Petrella L, et al. | Vaccine
Aim: To summarize and assess available data on the possible impact of COVID-19 vaccines on male and female fertility. UPDATED
|
|
|
9/23/22
|
Moore E, Fadel A, Lane KE, et al. | Nutr Health
Aim: To investigate the effects of consuming a Mediterranean diet on BMI and inflammatory markers of obese/overweight adults (?18 years) at risk of developing severe COVID-19 outcomes. UPDATED
|
|
|
9/22/22
|
Shahsavarinia K, Mahmoodpoor A, Sadeghi-Ghyassi F, et al. | Med J Islam Repub Iran
Aim: To systematically review the reported cases of Bell’s palsy following vaccination against COVID-19.
|
|
|
9/22/22
|
Spadaccio C, Pisani A, Salsano A, et al. | Open Med
Aim: To describe the epidemiological characteristics of MI mechanical complications and compare it with the temporal trends and outcomes of the pre-Covid-19 era.
|
|
|
9/20/22
|
Fazzini B, Battaglini D, Carenzo L, et al. | Br J Anaesth
Aim: To evaluate health-related quality of life (HRQoL), and physical and psychological impairments in ARDS survivors from 3 months to 5 yr follow-up after ICU discharge.
|
|
|
9/19/22
|
Cong WH, Saha BK, Tan CK | Prague Med Rep
Aim: To assess the efficacy of routine APP versus standard care in preventing death and invasive mechanical ventilation (IMV) in non-intubated hypoxic COVID-19 patients. UPDATED
|
|
|
9/19/22
|
Wang Z, Teng H, Wu X, et al. | Front Neurol
Aim: To evaluate the efficacy and safety of recanalization therapy for COVID-19 patients who suffered from AIS.
|
|
|
9/19/22
|
Yang CW, Chen RD, Zhu QR, et al. | Front Immunol
Aim: To evaluate the effectiveness of UC-MSCs inpatients with COVID-19. UPDATED
|
|
|
9/19/22
|
Trott M, Driscoll R, Pardhan S | Front Med
Aim: To examine the prevalence of persistent anosmia, hyposmia, ageusia, hypogeusia, as well as eye and ear related symptoms related long-COVID, across all populations, that persisted for longer than 12 weeks.
|
|
|
9/12/22
|
Hasan F, Chiu HY, Salamanca E, et al. | Eur J Dent
Aim: To examine the effects of chlorhexidine (CHX) and povidone-iodine (PVP-I) on the viral load in patients with COVID-19. UPDATED
|
|
|
9/7/22
|
Rahmig J, Altarsha E, Siepmann T, et al. | Neuropsychiatr Dis Treat
Aim: To systematically review the literature to summarize the available evidence on the association between SARS-CoV-2 vaccination and acute ischemic stroke.
|
|
|
9/6/22
|
Aljishi RS, Alkuaibi AH, Al Zayer FA, et al. | Cureus
Aim: To find the survival outcomes of patients with and without COVID-19 ARDS who were supported with extracorporeal membrane oxygenation (ECMO).
|
|
|
9/6/22
|
Peng Y, Zhong GC, Zhou X, et al. | BMC Geriatr
Aim: To quantify the associations of frailty status with all-cause and cause-specific mortality.
|
|
|
9/6/22
|
Shrestha AB, Aryal M, Magar JR, et al. | Ann Med Surg
Aim: To observe the current scenario of self-medication regarding the management or prevention of COVID-19. UPDATED
|
|
|
9/1/22
|
Ghasemi H, Darvishi N, Salari N, et al. | Trop Med Health
Aim: To evaluate the prevalence of polypharmacy among the COVID-19 patients, and the side effects, by systematic review and meta-analysis. UPDATED
|
|
|
8/30/22
|
Elshenawy RA, Umaru N, Alharbi AB, et al. | Research Square
Aim: To investigate the AMS intervention Pre-pandemic (PP) and During-the-pandemic (DP) from the literature. UPDATED
|
|
|
8/30/22
|
AlRasheed MM, Fekih-Romdhane F, Jahrami H, et al. | Sleep Med
Aim: To undertake an individual participant data (IPD) analysis to further investigate past meta-analyses, a method that has been shown to be more robust than standard meta-analyses.
|
|
|
8/30/22
|
Do B, Kirkland C, Besenyi GM, et al. | Prev Med Rep
Aim: To identify, evaluate, and synthesize evidence from available published literature examining the impact of the coronavirus disease 2019 (COVID-19) pandemic on youth physical activity (PA).
|
|
|
8/29/22
|
Kang H, Gu X, Tong Z | J Intensive Care Med
Aim: To assess whether APP can reduce the intubation rate and mortality of COVID-19 adults with acute hypoxemic respiratory failure than standard care.
|
|
|
8/29/22
|
Nabizadeh F, Ramezannezhad E, Kazemzadeh K, et al. | J Clin Neurosci
Aim: To perform a systematic review of case reports and case series studies to investigate the MS relapses after COVID-19 vaccination with most details.
|
|
|
8/29/22
|
Li M, Wang X, Feng J, et al. | Vaccines
Aim: To assess the incidence of myocarditis and pericarditis after COVID-19 vaccination in children and adolescents. UPDATED
|
|
|
8/29/22
|
Di Spirito F, Amato A, Di Palo MP, et al. | Int J Environ Res Public Health
Aim: To assess current data on cases diagnosed with oral lesions among adult subjects (?18 years old) who had received at least one dose of the World Health Organization (WHO) Emergency Use Listing approved [10] and European Medicines Agency (EMA) authorized [11] anti-SARS-CoV-2 vaccines, classify oral mucosal manifestations based on primary oral lesions, and describe their macroscopic and microscopic features. UPDATED
|
|
|
8/29/22
|
Xu X, Feng Y, Jia Y, et al. | Thromb Res
Aim: To review the evidence on the relationship between both VWF and its cleaving protease ADAMTS13 (a disintegrin and metalloproteinase with thrombospondin type 1 motif, member 13) with the prognosis of COVID-19. UPDATED
|
|
|
8/29/22
|
Alhumaid S, Rabaan AA, Dhama K, et al. | Vaccines
Aim: To delineate the range of organ rejections that were elicited following COVID-19 vaccination or SARS-CoV-2 infection.
|
|
|
8/29/22
|
Scarpelli S, Zagaria A, Ratti PL, et al. | Sleep Med
Aim: To provide an update on sleep quality in different world areas and better characterize subjective sleep alterations during the COVID-19 pandemic. UPDATED
|
|
|
8/26/22
|
Acute Arterial Ischemic Stroke Following COVID-19 Vaccination: A Systematic Review and Meta-analysis
 Stefanou MI, Palaiodimou L, Aguiar de Sousa D, et al. | Neurology
Aim: To provide the prevalence of arterial AIS following exposure to vectorbased and mRNA SARS-CoV-2 vaccines. UPDATED
|
|
|
8/26/22
|
Application of Telerehabilitation for Older Adults During the COVID-19 Pandemic: A Systematic Review
Ahmadi Marzaleh M, Peyravi M, Azhdari N, et al. | Disaster Med Public Health Prep
Aim: To evaluate the investigations that utilized telerehabilitation to assist elderly people during the COVID-19 pandemic. UPDATED
|
|
|
8/26/22
|
Chilkoti GT, Mohta M, Ahmad Z, et al. | Adv Respir Med
Aim: To evaluate the feasibility and efficacy of awake PP along with NIV in them.
|
|
|
8/25/22
|
Richter SA, Ferraz-Rodrigues C, Schilling LB, et al. | J Sleep Res
Aim: To review the evidence on the potential influence of the COVID-19 pandemic on sleep quality in children and adolescents. UPDATED
|
|
|
8/25/22
|
Luo W, Cai Q, Zhou Y, et al. | BMC Public Health
Aim: To analyze changes in parental feeding practices during COVID-19 that may help shape future interventions and make parental guidance more targeted.
|
|
|
8/24/22
|
Ezzatvar Y, Ramírez-Vélez R, Izquierdo M, et al. | Br J Sports Med
Aim: To quantify the association between physical activity and risk of SARS-CoV-2 infection, COVID-19-associated hospitalisation, severe illness and death due to COVID-19 in adults. UPDATED
|
|
|
8/24/22
|
Almadhoon HW, Hamdallah A, Elsayed SM, et al. | Sci Rep
Aim: To review the evidence on the link between influenza vaccination and the severity of COVID-19 infection. UPDATED
|
|
|
8/23/22
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the impact of the COVID-19 pandemic on the prevalence of eating disorders.
|
|
|
8/23/22
|
Vitória BA, Ribeiro MT, Carvalho VS | Front Psychol
Aim: To synthesize how COVID-19 has impacted the work-family interface. UPDATED
|
|
|
8/18/22
|
Siddiq S, Ahmed S, Akram I | Public Health
Aim: To evaluate the differences in clinical outcomes of COVID-19 infection between ethnic minorities and the White ethnic group in the UK. UPDATED
|
|
|
8/15/22
|
Matar RH, Mansour R, Nakanishi H, et al. | J Clin Med
Aim: To provide insight into the clinical characteristics of patients diagnosed with myocarditis following COVID-19 mRNA vaccination.
|
|
|
8/15/22
|
Hu W, Zhu Y, Wu Y, et al. | J Zhejiang Univ Sci B
Aim: To determine whether the COVID-19 pandemic had any adverse effects on female fertility and the pregnancy outcomes of women undergoing ART.
|
|
|
8/12/22
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on factors that influence the transmission of and immunological response to SARSCoV-2.
|
|
|
8/11/22
|
Thakur N, Das S, Kumar S, et al. | J Med Virol
Aim: To trace and understand the origin of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) through various available literatures and accessible databases.
|
|
|
8/11/22
|
Franco-Moreno AI, Bustamante-Fermosel A, Manuel Ruiz-Giardin J, et al. | Rev Clin Esp
Aim: To discover the utility of probability models developed for PE in patients with COVID-19 by reviewing the available literature.
|
|
|
8/9/22
|
Ding S, Deng S, Zhang Y, et al. | Front Public Health
Aim: To explore front-line nurses' experiences and needs during the COVID-19 pandemic through a qualitative meta-synthesis. UPDATED
|
|
|
8/9/22
|
Yang Z, Wang X, Zhang S, et al. | Front Public Health
Aim: To compare myopia progression in children before the COVID-19 pandemic and during COVID-19 pandemic home quarantine and at the same time explore the risk factors of myopia progression. UPDATED
|
|
|
8/9/22
|
Whear R, Bethel A, Abbott R, et al. | J Clin Epidemiol
Aim: To suggest possible approaches to combatting the impact of the COVID-19 infodemic in-order to prevent research waste in future health emergencies and in everyday research and practice. UPDATED
|
|
|
8/8/22
|
Martinez-Reviejo R, Tejada S, Adebanjo GAR, et al. | Eur J Intern Med
Aim: To summarize the evidence concerning clinical VZV reactivation following SARS-CoV-2 vaccination.
|
|
|
8/5/22
|
Pilia E, Belletti A, Fresilli S, et al. | J Thromb Thrombolysis
Aim: To investigate the efficacy and safety of heparin full-dose anticoagulation in hospitalized non-critically ill COVID-19 patients.
|
|
|
8/5/22
|
Meshram HS, Kute V, Rane H, et al. | Transpl Infect Dis
Aim: To analyze the humoral and cellular response to standard and booster (additional doses) COVID-19 vaccination in solid organ transplantation (SOT) and the risk factors involved for an impaired response. UPDATED
|
|
|
8/3/22
|
Meyer D, Slone SE, Ogungbe O, et al. | AIDS Behav
Aim: To assess the impacts of the pandemic on service engagement, treatment adherence, and viral suppression. UPDATED
|
|
|
8/3/22
|
Khokher W, Malhas SE, Beran A, et al. | J Intensive Care Med
Aim: To evaluate the role of IPVD in COVID-19 patients.
|
|
|
8/2/22
|
Ahmed I, Mustafaoglu R, Yeldan I, et al. | Arch Phys Med Rehabil
Aim: To qualitatively synthesize and quantitatively evaluate the effect of pulmonary rehabilitation (PR) on dyspnea, lung functions, fatigue, exercise capacity, and quality of life (QoL) in patients with COVID-19.
|
|
|
8/2/22
|
Nourmohammadi H, Dehkordi AH, Adibi A, et al. |
Aim: To estimate the seroprevalence of COVID-19 in blood donors in the world.
|
|
|
7/28/22
|
Migliorini F, Vaishya R, Eschweiler J, et al. | Medicina
Aim: To provide an account of the role played by vitamins C and D on the onset, progression and severity of COVID-19.
|
|
|
7/27/22
|
Al-Qudimat AR, Al-Zoubi RM, Elaarag M, et al. | Health Sci Rep
Aim: To offer healthcare workers and non?healthcare workers a comprehensive and up?to?date overview of the currently available information on the severity of the BioNTech?Pfizer vaccine in children and adolescents.
|
|
|
7/27/22
|
Federspiel JM, Ramsthaler F, Kettner M, et al. | Rechtsmedizin
Aim: To summarize of the current knowledge on mRNA vaccination-associated myocarditis as a potentially fatal side effect.
|
|
|
7/27/22
|
Nazir M, Asghar S, Rathore MA, et al. | Vacunas
Aim: To give a comprehensive interpretation of menstrual cycle changes after the COVID-19 vaccination.
|
|
|
7/25/22
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence for alternative models of care for managing patients with acute medical conditions outside of emergency or inpatient hospital settings.
|
|
|
7/25/22
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the effectiveness of oseltamivir on adults and children in a healthcare setting.
|
|
|
7/25/22
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on post-acute sequelae of COVID-19 infection. UPDATED
|
|
|
7/19/22
|
Kariya A, Krutsri C, Singhatas P, et al. | Int J Surg Open
Aim: To analyze the rate of complicated appendicitis before and during the COVID-19 pandemic. UPDATED
|
|
|
7/19/22
|
Hessami K, Sayegh N, Abdolmaleki AS, et al. | J Obstet Gynaecol Res
Aim: To systematically review and summarize the available literature regarding the women's sexual function during COVID-19 pandemic and compare it to pre-pandemic period. UPDATED
|
|
|
7/14/22
|
| NSW Health COVID-19 Critical Intelligence Unit
|
|
|
7/14/22
|
| NSW Health COVID-19 Critical Intelligence Unit
|
|
|
7/14/22
|
Baradaran HR, Dehghanbanadaki H, Moradpour F, et al. | Expert Rev Vaccines
Aim: To investigate the pooled effect of COVID-19 mRNA vaccination against SARS-CoV-2 infection and its clinical outcomes. UPDATED
|
|
|
7/14/22
|
Rahmati M, Keshvari M, Mirnasuri S, et al. | J Med Virol
Aim: To estimate the risk of global pediatric new-onset T1D, DKA, and severe DKA before and after the COVID-19 pandemic.
|
|
|
7/13/22
|
Saragih ID, Tarihoran DETAU, Rasool A, et al. | J Nurs Scholarsh
Aim: To update estimates of the prevalence of stigmatization and violence against healthcare workers during the pandemic. UPDATED
|
|
|
7/13/22
|
Tunjungputri RN, Tetrasiwi EN, Mulansari NA, et al. | Acta Med Indones
Aim: To provide the most recent update on available evidence on the clinical benefits and risk of oral and parenteral anticoagulants, as well agents with anticoagulant properties, in hospitalized and post-discharge COVID-19 patients.
|
|
|
7/13/22
|
Dobrijevic Z, Gligorijevic N, Sunderic M, et al. | Rev Med Virol
Aim: To elucidate the potential involvement of genetic variability within HLA loci in the molecular genetics of COVID-19.
|
|
|
7/13/22
|
Bitar AN, Sulaiman SAS | Curr Med Res Opin
Aim: To evaluate the evidence from clinical trials on the effect of colchicine and corticosteroids against COVID-19. UPDATED
|
|
|
7/13/22
|
Tugasworo D, Kurnianto A, Retnaningsih, et al. | Egypt J Neurol Psychiatr Neurosurg
Aim: To assess and conclude the research-based study systematically to analyze the relationship of MG and COVID-19. UPDATED
|
|
|
7/12/22
|
Nazari T, Sadeghi F, Izadi A, et al. | PLoS One
Aim: To summarize the studies that have reported CAFIs in Iran. UPDATED
|
|
|
7/12/22
|
Neville RD, Lakes KD, Hopkins WG, et al. | JAMA Pediatr
Aim: To estimate whether changes in physical activity differed between participant-level, contextual, and methodological moderators during the COVID-19 pandemic. UPDATED
|
|
|
7/12/22
|
Bass JR, Poland GA | Vaccine
Aim: To describe SIRVA in the current pandemic, increase clinician awareness, and offer considerations for prevention.
|
|
|
7/11/22
|
Carbone L, Trinchillo MG, Di Girolamo R, et al. | Int J Gynaecol Obstet
Aim: To explore perinatal outcomes in SARS-CoV-2 vaccinated pregnant women comparing with unvaccinated counterparts.
|
|
|
7/11/22
|
Wu HT, Ji CH, Dai RC, et al. | J Integr Med
Aim: To systematically evaluate the methodological quality and quality of evidence in the published systematic reviews and meta-analyses on the use of TCM in the treatment of COVID-19.
|
|
|
7/6/22
|
Moura-Coelho N, Cunha JP, Papa-Vettorazzi R, et al. | Acta Ophthalmol
Aim: To examine all the documented cases of acute corneal allograft rejection following SARS-CoV-2 vaccination, and to characterize possible risk factors and graft outcomes after rejection.
|
|
|
7/6/22
|
Barmanray RD, Cheuk N, Fourlanos S, et al. | BMJ Open Diabetes Res Care
Aim: To quantify the association between diabetes, hyperglycemia, and outcomes in patients hospitalized for community-acquired pneumonia (CAP) prior to the COVID-19 pandemic.
|
|
|
7/6/22
|
Behers BJ, Patrick GA, Jones JM, et al. | Yale J Biol Med
Aim: To perform an in-depth analysis of documented case reports of individuals who developed myocarditis following administration of either the Pfizer or Moderna vaccine.
|
|
|
7/6/22
|
Halabchi F, Selk-Ghaffari M, Tazesh B, et al. | Sport Sci Health
Aim: To investigate the role of exercise rehabilitation programs, either in acute or post-acute phase, on physical and psychological outcomes among COVID-19 patients. UPDATED
|
|
|
7/1/22
|
Almeda N, Gomez-Gomez I | Front Psychiatry
Aim: To analyse the changes in smoking consumption during the COVID-19 pandemic through longitudinal studies. UPDATED
|
|
|
6/28/22
|
Kolahchi Z, Khanmirzaei M, Mowla A | J Neurol Sci
Aim: To review the evidence on the incidence of AIS after COVID-19 vaccination.
|
|
|
6/28/22
|
Yang W, Zhang D, Li Z, et al. | Eur J Cancer
Aim: To assess the factors that predict poor seroconversion comprehensively in order to plan better prevention strategies in this frail population.
|
|
|
6/24/22
|
Roshdy A, Elsayed AS, Saleh AS | J Intensive Care Med
Aim: To explore the evidence surrounding the use of Airway Pressure Release Ventilation (APRV) in patients with coronavirus disease 2019 (COVID-19). UPDATED
|
|
|
6/24/22
|
Rozani S, Evangelou K, Schuffert L, et al. | Chirurgie (Heidelb)
Aim: To investigate the reasons for the occurrence of substance dependence and burnout in surgeons and anesthesiologists timelessly and during the COVID-19 pandemic and what improvement measures could help in the clinical practice?
|
|
|
6/24/22
|
Gioia F, Albasata H, Hosseini-Moghaddam SM | J Fungi
Aim: To evaluate studies reporting concomitant COVID-19 and Pneumocystis jirovecii pneumonia (PJP).
|
|
|
6/24/22
|
Morello R, Pepe M, Martino L, et al. | Acta Paediatr
Aim: To summarize the cases of myopericarditis after COVID-19 vaccination in pediatric patients and describe its incidence, clinical features, diagnostic pathways, therapeutic strategies and outcome.
|
|
|
6/24/22
|
Boet S, Etherington C, Ghanmi N, et al. | Diving Hyberb Med
Aim: To review the evidence on hyperbaric oxygen treatment (HBOT) for hypoxaemic COVID-19 patients.
|
|
|
6/24/22
|
Raquib A, Raquib R, Jamil S, et al. | Front Med
Aim: To review the evidence on the KAP for COVID-19 prevention in Bangladesh.
|
|
|
6/24/22
|
Santabárbara J, Olaya B, Bueno-Notivol J, et al. | Rev Med Chil
Aim: To review the prevalence of depression in medical students during the COVID-19 pandemic.
|
|
|
6/24/22
|
Zhang M, Yan X, Shi M, et al. | Glob Health Res Policy
Aim: To reviewe the safety and efficiency of stem cell therapy in COVID-19 cases.
|
|
|
6/21/22
|
Li L, Wang F, Shui X, et al. | PLoS One
Aim: To evaluate the pooled estimated level of knowledge, attitudes, and practices (KAP) about COVID-19 among college students in China. UPDATED
|
|
|
6/21/22
|
Ramzi ZS, Fatah PW, Dalvandi A | Front Pyschol
Aim: To estimate the overall prevalence of WPV against HCWs.
|
|
|
6/21/22
|
Antonini M, Hinwood M, Paolucci F, et al. | World J Surg
Aim: To investigate changes in the epidemiology of major trauma presentations during the implementation of movement restriction measures to manage the first wave of the SARS-CoV-2 (COVID-19) pandemic. UPDATED
|
|
|
6/17/22
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the current and emerging patient safety issues arising from the COVID-19 pandemic.
|
|
|
6/17/22
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on seasonal influenza prophylaxis in healthcare and aged care settings.
|
|
|
6/17/22
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence for rapid access models of care for respiratory illnesses, especially during winter seasons, in emergency departments.
|
|
|
6/16/22
|
Chun HR, Cheon E, Hwang JE | BMJ Open
Aim: To examine changed smoking behaviours, cessation intentions and associated psychological states among smokers during the COVID-19 pandemic.
|
|
|
6/15/22
|
Hatami H, Deravi N, Danaei B, et al. | Int J Methods Psychiatr Res
Aim: To investigate the effectiveness of telephone-delivered services for psychological disorders in the COVID-19 pandemic.
|
|
|
6/14/22
|
Messova A, Pivina L, Muzdubayeva Z et al. | J Emerg Nurse
Aim: To review the evidence on the pathophysiology, symptoms, and treatment of COVID-19-mediated immunoglobulin A vasculitis.
|
|
|
6/14/22
|
Motwani R, Deshmukh V, Kumar A, et al. | Infez Med
Aim: To review and summarize histopathological and ultrastructural changes in the placental tissue following SARS-CoV-2 infection.
|
|
|
6/14/22
|
Battaglini D, Premraj L, Huth S, et al. | J Neurosurg Anesthesiol
Aim: To investigate the use of noninvasive multimodal neuromonitoring in critically ill adult patients with COVID-19 infection. UPDATED
|
|
|
6/13/22
|
Kirby A, Drummond FJ, Lawlor A, et al. | Support Care Cancer
Aim: To examine the social, psychological, and economic impacts of COVID-19 on cancer patients. UPDATED
|
|
|
6/10/22
|
Ndayishimiye C, Lopes H, Middleton J | Research Square
Aim: To investigate how digital health technologies (DHTs) evolved to support the PHC sector during COVID-19 and lessons for the future improvement of PHC.
|
|
|
6/10/22
|
Senderovich H, Vinoraj D, Stever M, et al. | Ther Adv Infect Dis
Aim: To assess the current knowledge of the COVID-19 treatment modalities for the geriatric population.
|
|
|
6/10/22
|
Mogharab V, Ostovar M, Ruszkowski J, et al. | Global Health
Aim: To compare the incidence of endpoints marking delayed healthcare seeking in medical emergencies, before and during the pandemic.
|
|
|
6/10/22
|
Loo WK, Hasikin K, Suhaimi A, et al. | Front Public Health
Aim: To understand the current trends and progress in mitigation of hospital readmissions due to COVID-19.
|
|
|
6/9/22
|
Kouhpayeh H, Ansari H | Int Immunopharmacol
Aim: To determine the risk and clinical features of adverse reactions following immunization of the COVID-19.
|
|
|
6/9/22
|
Bezerra GMF, de Lucena Feitosa ES, Vale Catunda JG, et al. | Stud Health Technol Inform
Aim: To review studies on applied telemedicine during the COVID-19 pandemic and had assess its effects on the delivered care.
|
|
|
6/8/22
|
Washrawirul C, Triwatcharikorn J, Phannajit J, et al. | J Eur Acad Dermatol Venereol
Aim: To assess the global prevalence and clinical manifestations of cutaneous adverse reactions following COVID-19 vaccination.
|
|
|
6/7/22
|
Aryana IGPS, Setiati S, Paulus IB, et al. | J Nutr Metab
Aim: To investigate physical training on muscle health and QOL in patients with COVID-19. UPDATED
|
|
|
6/6/22
|
Mirzay-Razaz J, Hassanghomi M, Ajami M, et al. | BMC Nutr
Aim: To review effective food hygiene principles and dietary intakes to reinforce the immune system for prevention of corona virus disease 2019 (COVID-19).
|
|
|
6/3/22
|
Perez-Lopez FR, Lopez-Baena MT, Perez-Roncero G, et al. | Gynecol Endocrinol
Aim: To compare the female sexual function before and during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic using the Female Sexual Function Index (FSFI).
|
|
|
6/3/22
|
Park DY, An S, Kaur A, et al. | Clin Cardiol
Aim: To review the evidence on COVID-19 vaccine-associated myocarditis, delineating its demographics and clinical characteristics.
|
|
|
6/2/22
|
Pourasghari H, Tavolinejad H, Soleimanpour S, et al. | Int J Cardiol Heart Vasc
Aim: To compare the rate of AMI admissions and major complication during the pandemic, in comparison with pre-pandemic periods.
|
|
|
6/1/22
|
Zhang L, Ma Y, Shi N, et al. | Phytomedicine
Aim: To systematically assemble the evidence on the efficacy and safety of QFPDD combined with Western medicine treatments (WMT) for COVID-19.
|
|
|
5/31/22
|
Parmar K, Subramanyam S, Del Rio-Pertuz G, et al. | Vaccines
Aim: To investigate the patient characteristics and provide an overview of the management for patients that develop AEs after vaccination.
|
|
|
5/31/22
|
Trott M, Driscoll R, Irlado E, et al. | EClinicalMedicine
Aim: To (a) aggregate changes in screen time in adults and children, and (b) report on variables in relation to screen time during the COVID-19 pandemic.
|
|
|
5/31/22
|
Dadras O, SeyedAlinaghi S, Karimi A, et al. | Health Sci Rep
Aim: To systematically review the mortality rates in older patients compared to young patients.
|
|
|
5/31/22
|
Toro-Huamanchumo CJ, Castro-Reyes MM, Peralta V, et al. | Int J Environ Res Public Health
Aim: To assess the efficacy and safety of extracorporeal membrane oxygenation (ECMO) in patients under mechanical ventilation with COVID-19 and severe acute respiratory distress syndrome (ARDS).
|
|
|
5/31/22
|
Panneer S, Kantamaneni K, Palaniswamy U, et al. | Healthcare
Aim: To explore health, economic and social development issues in a COVID-19 pandemic context and aftermath.
|
|
|
5/31/22
|
Degarege A, Naveed Z, Kabayundo J, et al. | Pathogens
Aim: To review the evidence on the risk factors of severe illness, admission to the ICU, and death among COVID-19 patients, and we assessed the sources of heterogeneity and publication bias among the studies.
|
|
|
5/31/22
|
Loader J, Taylor FC, Lampa E, et al. | J Am Heart Assoc
Aim: To assess the extent of bias in that research and reevaluated RAAS inhibitor-COVID-19 associations in studies without critical risk of bias. UPDATED
|
|
|
5/31/22
|
Sasidharanpillai S, Ravishankar N | Asian Pac J Cancer Prev
Aim: To assess the pooled proportion of women screened for cervical cancer before and during the COVID-19 pandemic.
|
|
|
5/26/22
|
Cui X, Zhai Y, Wang S, et al. | Med Sci Monit
Aim: To systemically evaluate the effect of the COVID-19 pandemic on serum vitamin D levels in people under age 18 years.
|
|
|
5/25/22
|
Zhai K, Xu X, Zhang P, et al. | Perfusion
Aim: To evaluate the effect of VV-ECMO in the treatment of patients with COVID-19.
|
|
|
5/24/22
|
O'Mahoney LL, Highton PJ, Kudlek L, et al. | Diabetes Obes Metab
Aim: To identify, appraise and synthesise available evidence on the impact of the pandemic on glycaemic control in people with diabetes. UPDATED
|
|
|
5/23/22
|
Kudhail K, Thompson J, Mathews V, et al. | Int J Infect Dis
Aim: To describe the prevalence of risks of bias in randomised trials of therapeutic interventions for COVID-19.
|
|
|
5/23/22
|
Kim H, Hughes E, Cavanagh A, et al. | PLoS One
Aim: To conduct a mixed methods systematic review on the impacts of the COVID-19 pandemic on the health of people who experience imprisonment. UPDATED
|
|
|
5/16/22
|
Landoni G, Belloni O, Russo G, et al. | J Clin Med
Aim: To identify all the literature published and all the currently ongoing trials on volatile anesthetics in COVID-19 patients to enlighten the pros/cons of their role in this setting.
|
|
|
5/16/22
|
Juneau CE, Pueyo T, Bell M, et al. | Syst Rev
Aim: To provide a comprehensive summary of the evidence on past pandemic controls, with a focus on cost-effectiveness.
|
|
|
5/16/22
|
Teschke R, Méndez-Sánchez N, Eickhoff A | Int J Mol Sci
Aim: To analyze published reports on conventional drugs and their role in causing liver injury among COVID-19 patients.
|
|
|
5/16/22
|
Fugazzaro S, Contri A, Esseroukh O, et al. | Int J Environ Res Public Health
Aim: To explore the effectiveness of rehabilitation interventions for adult patients with PACS by reporting the main changes in outcomes after the experimental interventions. UPDATED
|
|
|
5/16/22
|
Mani A, Ojha V | Ann Vasc Surg
Aim: To systematically review thromboembolic events reported after Covid-19 vaccination.
|
|
|
5/13/22
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on emerging SARS-CoV-2 variants.
|
|
|
5/4/22
|
| NSW Health COVID-19 Critical Intelligence Unit
|
|
|
5/4/22
|
| NSW Health COVID-19 Critical Intelligence Unit
|
|
|
5/2/22
|
Umesh A, Pranay K, Pandey RC, et al. | Infection
Aim: To perform a rapid review and evidence mapping of systemic complications and symptoms of long-COVID and underlying pathophysiological mechanisms.
|
|
|
4/22/22
|
Luo S, Liang Y, Wong THT, et al. | Int J Epidemiol
Aim: To summarize modifiable factors for coronavirus disease 2019 (COVID-19) suggested by Mendelian randomization studies. UPDATED
|
|
|
4/21/22
|
Sankova MV, Nikolenko VN, Oganesyan MV, et al. | Curr Drug Targets
Aim: To evaluate the pathogenetic relationship between gut microbiota, immunological reactivity disruption and microbiota pathologies with the new coronavirus infection's course in order to substantiate the use of current drugs correcting gut microbiota during the SARS-CoV-2 pandemic.
|
|
|
4/21/22
|
Vinayagamoorthy K, Pentapati KC, Prakash H | Mycoses
Aim: To address the prevalence, underlying diseases, iatrogenic risk factors, treatment and outcome of C. auris infections in COVID-19 patients.
|
|
|
4/14/22
|
Panda SK, Mishra A, Pathak M | Cureus
Aim: To analyze the clinical outcomes and SARS-CoV-2 infectivity of neonates born to SARS-CoV-2 positive mothers in India from published literature.
|
|
|
4/14/22
|
| NSW Health COVID-19 Critical Intelligence Unit
|
|
|
4/14/22
|
Manothummetha K, Chuleerarux N, Sanguankeo A, et al. | JAMA Netw Open
Aim: To summarize current evidence on vaccine responses and identify risk factors for diminished humoral immune response in recipients of SOT.
|
|
|
4/14/22
|
Su W, Wang H, Sun C, et al. | Am J Prev Med
Aim: To assess the association between previous influenza vaccination and COVID-19 on the basis of the available evidence. UPDATED
|
|
|
4/8/22
|
Han P, Duan X, Zhao S, et al. | Front Public Health
Aim: To summarize and evaluate the actual psychological experience of nurses caring for patients with severe pneumonia in the ICUs during the COVID-19 pandemic.
|
|
|
4/8/22
|
Marmitt DJ | Inflammopharmacology
Aim: To select clinical trials with anti-inflammatory plants and relate the activity of these plants to inflammatory markers of SARS-CoV-2 infection.
|
|
|
4/5/22
|
Ao G, Li A, Wang Y, et al. | Am J Emerg Med
Aim: To investigate the association between opioid usage and COVID-19 prognosis. UPDATED
|
|
|
4/4/22
|
Mondal R, Mishra S, Pillai JSK, et al. | J Family Prim Med Care
Aim: To identify the impacts of the pandemic on biomedical waste management.
|
|
|
3/28/22
|
Alboksmaty A, Beaney T, Elkin S, et al. | Lancet Digit Health
Aim: To assess the effectiveness and safety of the use of pulse oximetry in the remote monitoring of patients at home with COVID-19. UPDATED
|
|
|
3/24/22
|
Alimoradi Z, Ohayon MM, Griffiths MD, et al. | BJPsych Open
Aim: To synthesize empirical evidence to understand fear of COVID-19 and its associations with mental health-related problems during this pandemic period. UPDATED
|
|
|
3/24/22
|
Seyferth AV, Wood SM, Kane RL, et al. | Plast Reconstr Surg
Aim: To quantify the prevalence of ethical discussions and representation of the four ethical principles in COVID-19 research, and to identify which principles and topics are underrepresented across scientific disciplines.
|
|
|
3/11/22
|
| NSW Health COVID-19 Critical Intelligence Unit
UPDATED
|
|
|
3/11/22
|
Tao K, Tzou PL, Pond SLK, et al. | Preprints.org
Aim: To review the evidence on the in vitro activity of authorized mAbs against the Omicron variants.
|
|
|
3/9/22
|
Kariyawasam RM, Julien DA, Jelinski DC, et al. | Antimicrob Resist Infect Control
Aim: To quantify the prevalence and types of resistant co-infecting organisms in patients with COVID-19 and explore differences across hospital and geographic settings. UPDATED
|
|
|
2/25/22
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on budesonide and aspirin for pregnant women with COVID-19.
|
|
|
2/25/22
|
| NSW Health COVID-19 Critical Intelligence Unit
|
|
|
2/22/22
|
Rottler M, Ocskay K, Sipos Z, et al. | Ann Intensive Care
Aim: To summarize the evidence on the efficacy of frailty tools in risk assessment in COVID-19 patients. UPDATED
|
|
|
2/22/22
|
Camacho-Montaño LR, Iranzo A, Martínez-Piédrola RM, et al. | Sleep Med Rev
Aim: To examine the evidence of the effects of coronavirus disease confinement on the sleep of children aged 12 years and younger.
|
|
|
2/22/22
|
| Pan American Health Organization
Aim: To review the evidence on the therapeutic options for COVID-19. UPDATED
|
|
|
2/21/22
|
Zhang G, Kuang S, Zhang X | Hum Vaccin Immunother
Aim: To evaluate the reporting quality of COVID-19 vaccine randomized controlled trials (RCTs).
|
|
|
2/21/22
|
Elvidge J, Summerfield A, Nicholls D, et al. | Value Health
Aim: To review economic evaluations of diagnostic tests and treatments for COVID-19. UPDATED
|
|
|
2/18/22
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the COVID-19 pandemic and the wellbeing of critical care and other healthcare workers.
|
|
|
2/18/22
|
Du Z, Liu C, Wang C, et al. | Clin Infect Dis
Aim: To review the evidence on reproduction numbers of SARS-CoV-2 variants.
|
|
|
2/17/22
|
Xiao K, Gillissie ES, Lui LMW, et al. | J Affect Disord
Aim: To determine whether individuals with mental disorders exhibit differential immune response following the administration of vaccines for other infections.
|
|
|
2/17/22
|
Badenoch JB, Rengasamy ER, Watson C, et al. | Brain Commun
Aim: To determine the prevalence of neuropsychiatric symptoms in survivors of COVID-19. UPDATED
|
|
|
2/16/22
|
Schmidbauer ML, Ferse C, Salih F, et al. | J Clin Med
Aim: To systematically investigate incidence, mortality, radiological subtypes and clinical characteristics of ICH in COVID-19 patients. UPDATED
|
|
|
2/16/22
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence regarding post-acute and subacute care for COVID-19 patients. UPDATED
|
|
|
2/16/22
|
Yeun YR, Kim SD | Int J Environ Res Public Health
Aim: To explore the psychological effects of online-based mindfulness programs during the COVID-19 pandemic.
|
|
|
2/15/22
|
Clark SE, Chisnall G, Vindrola-Padros C | EClinicalMedicine
Aim: To identify the supportive and operational strategies used for the flexible de-escalation of ICUs in the context of COVID-19. UPDATED
|
|
|
2/15/22
|
S?omka A, Kowalewski M, ?ekanowska E | Thromb Haemost
Aim: To assess the performance of TEG and TEM in the assessment of blood coagulation and fibrinolysis in patients with COVID-19.
|
|
|
2/11/22
|
| NSW Health COVID-19 Critical Intelligence Unit
|
|
|
2/11/22
|
| NSW Health COVID-19 Critical Intelligence Unit
|
|
|
2/11/22
|
| NSW Health COVID-19 Critical Intelligence Unit
|
|
|
2/9/22
|
Cuninghame S, Gorsky K, Francoeur C, et al. | BMJ Open
Aim: To summarise the known effects of inhaled sedatives on cognitive and psychiatric outcomes.
|
|
|
2/9/22
|
Brown C, Wilkins K, Craig-Neil A, et al. | Public Health Rev
Aim: To identify the areas of greatest concern and synthesize recommendations to support a more equitable pandemic response.
|
|
|
2/9/22
|
Jahrami HA, Alhaj OA, Humood AM, et al. | Sleep Med Rev
Aim: To evaluate the extent of sleep disturbances during the COVID-19 pandemic. UPDATED
|
|
|
2/8/22
|
Mendoza JPIM, Ubillús BPT, Bolívar GTS, et al. | Saudi Dent J
Aim: To evaluate the antiviral effect of mouthwashes against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). UPDATED
|
|
|
2/8/22
|
Abas?yan?k Z, Kurt M, Kahraman T | J Dev Phys Disabil
Aim: To investigate the physical activity changes in people with neurological diseases, and to examine the relationship between physical activity and disease symptoms, and psychosocial factors. UPDATED
|
|
|
2/7/22
|
Aldukhayel A | Endokrynol Pol
Aim: To synthesize evidence on the impact of the COVID-19 lockdown on the glycaemic control, physical activity, and diet of diabetic patients.
|
|
|
2/4/22
|
| National Collaborating Centre for Methods and Tools
Aim: To review the evidence on the risk of transmission of COVID-19 within post-secondary institutions and the strategies to mitigate on-campus outbreaks? UPDATED
|
|
|
2/2/22
|
| COVID-END
Aim: To review the evidence on the efficacy and effectiveness of available COVID-19 vaccines for variants of concern. UPDATED
|
|
|
2/1/22
|
Pogorelic Z, Anand S, Artukovic L, et al. | J Pediatr Urol
Aim: To evaluate whether the Coronavirus Disease 2019 (COVID-19) pandemic resulted in a prolonged duration of symptoms, a delayed presentation to the medical facility, and consequently more orchiectomy procedures among children with testicular torsion compared to the pre-COVID-19 period.
|
|
|
1/31/22
|
Adham M, Anam K, Reksodiputro L | Med J Malaysia
Aim: To review and discuss existing research on treatment prioritization and risk stratification of head and neck cancer patients during the pandemic.
|
|
|
1/28/22
|
| CADTH
Aim: To provide a summary of resources and literature about the outcomes and impacts of COVID-19 on Indigenous populations in Canada.
|
|
|
1/27/22
|
Kharel M, Sakamoto JL, Carandang RR, et al. | BMJ Glob Health
Aim: To examine the impact of COVID-19 lockdown on children and adolescents' movement behaviours. UPDATED
|
|
|
1/27/22
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on cases of COVID-19 on the pediatric population in Australia.
|
|
|
1/24/22
|
Schmid B, Griesel M, Fischer AL, et al. | J Clin Med
Aim: To analyze the available evidence on HFNC vs. NIV and APP vs. standard of care (SoC) on COVID-19-associated respiratory failure. UPDATED
|
|
|
1/24/22
|
Pogorelic Z, Anand S, Zuvela T, et al. | Diagnostics
Aim: To evaluate whether the COVID-19 pandemic resulted in higher incidence of complicated appendicitis in children presenting with acute appendicitis compared to the pre-COVID-19 period.
|
|
|
1/24/22
|
Jaljaa A, Caminada S, Tosti ME, et al. | BMC Public Health
Aim: To assess the risk of infection of migrants and ethnic minorities in the 53 countries belonging to the World Health Organization European Region, during the first year of the pandemic. UPDATED
|
|
|
1/21/22
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the effectiveness of Sotrovimab as a treatment for COVID-19.
|
|
|
1/19/22
|
Masuda Y, Teoh SE, Yeo JW, et al. | Sci Rep
Aim: To investigate the effect of the COVID-19 pandemic on the pre-hospital chain of survival. UPDATED
|
|
|
1/18/22
|
| National Collaborating Centre for Methods and Tools
Aim: To review the evidence on the risk factors associated with severe COVID-19 outcomes in children 12 years and under. UPDATED
|
|
|
1/18/22
|
Heneghan CJ, Spencer EA, Brassey J, et al. | F1000Res
Aim: To systematically review the evidence on orofecal SARS-CoV-2 transmission. UPDATED
|
|
|
1/13/22
|
Williams BE, Kondo KK, Ayers CK, et al. | Health Equity
Aim: To identify interventions that have effectively reduced disparities in health outcomes in infectious disease outbreaks or natural disasters in the United States and understand whether such interventions could be applied to reduce health disparities in the current COVID-19 pandemic. VA ESP
|
|
|
1/12/22
|
Niquini RP, Corrêa da Mota J, Bastos LS, et al. | Sci Rep
Aim: To assess HCV infection rates in haemodialysis patients in Brazil.
|
|
|
1/10/22
|
Bakr AM, El-Sakka AI, et al. | Int J Impot Res
Aim: To review the evidence on the change in erectile function among patients and health care providers during the COVID-19 pandemic. UPDATED
|
|
|
1/10/22
|
Saengsiwaritt W, Jittikoon J, Chaikledkaew U, et al. | Rev Med Virol
Aim: To clarify associations of genetic variants in those genes with COVID-19 susceptibility and severity.
|
|
|
1/10/22
|
Vera San Juan N, Clark SE, Camilleri M, et al. | BMJ Open
Aim: To provide a detailed understanding of redeployment and training during the first year of the COVID-19 pandemic by capturing and considering the merit of the strategies enlisted and the experiences and needs of redeployed healthcare workers (HCWs).
|
|
|
1/8/22
|
Edwards A, Cooper A, Lewis R, et al. | Wales COVID-19 Evidence Centre
Aim: To review the evidence on the transmission risk of SARS-CoV-2 from vaccinated people to unvaccinated or vaccinated people.
|
|
|
1/6/22
|
Bielski K, Makowska K, Makowski A, et al. | Cardiol J
Aim: To update the information about the impact of coronavirus disease 2019 (COVID-19) pandemic on outcomes of in-hospital cardiac arrest (IHCA).
|
|
|
1/1/22
|
| Wales COVID-19 Evidence Centre
Aim: To review the evidence on the barriers and facilitators for adopting PPBs in various settings.
|
|
|
12/29/21
|
Oliveira MR, Sudati IP, Konzen VM, et al. | Exp Gerontol
Aim: To evaluate the available evidence related to the level of physical activity (PA) of elderly people during the COVID-19 pandemic. UPDATED
|
|
|
12/24/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the COVID-19 variant of concern dubbed Omicron. UPDATED
|
|
|
12/23/21
|
Katsanos A, Palaiodimou L, Zand R, et al | Stroke
Aim: To evaluate the impact of COVID-19 pandemic on stroke epidemiology and care across the world. UPDATED
|
|
|
12/22/21
|
Mukherjee TI, Khan AG, Dasgupta A, et al. | Reprod Health
Aim: To systematically review empirical evidence of the indirect impacts of respiratory epidemics on SRH.
|
|
|
12/20/21
|
Deng D, Liang A, Chui JN, et al. | Nephrology
Aim: To evaluate the effect of the COVID-19 pandemic on access to healthcare for patients with CKD. UPDATED
|
|
|
12/16/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the efficacy of face masks in helping to prevent the spread of COVID-19. UPDATED
|
|
|
12/13/21
|
Burns KEA, Laird M, Stevenson J, et al. | JAMA Netw Open
Aim: To appraise the quality of clinical practice guidelines (CPGs) using the National Academy of Medicine (NAM) criteria. UPDATED
|
|
|
12/13/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the use of monoclonal antibodies for the treatment of COVID-19.
|
|
|
12/13/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the safety and efficacy of COVID-19 vaccination in renal dialysis patients.
|
|
|
12/13/21
|
Elisabeth AL, Karlen SB, Magkos F | Aging Dis
Aim: To conduct a thorough analysis of the current literature on the effects of the COVID-19-related lockdowns on diet and physical activity habits in older individuals. UPDATED
|
|
|
12/13/21
|
Bielski K, Szarpak A, Jaguszewski MJ, et al. | J Clin Med
Aim: To evaluate the influence of COVID-19 on OHCA survival outcomes.
|
|
|
12/8/21
|
Teoh SE, Masuda Y, Tan DJH, et al. | Ann Intensive Care
Aim: To evaluate the impact of the pandemic on the incidence and case fatality rate (CFR) of OHCA. UPDATED
|
|
|
12/6/21
|
Ghahramani S, Lankarani KB, Yousefi M, et al. | Front Psychiatry
Aim: To present a comprehensive picture of the prevalence of burnout among healthcare workers during the COVID-19 pandemic. UPDATED
|
|
|
12/6/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on fomites as a transmission route for COVID-19 infection.
|
|
|
12/6/21
|
Yunitri N, Chu H, Kang XL, et al. | Int J Nurs Stud
Aim: To examine the global prevalence and associated risk factors of PTSD in patients/survivors of COVID-19, health professionals, and the population at large. UPDATED
|
|
|
12/6/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on paediatric respiratory infections following lockdown and school reopening.
|
|
|
12/6/21
|
Mirashrafi S, Moravejolahkami AR, Balouch Zehi Z, et al. | Clin Nutr ESPEN
Aim: To conduct a rapid review of probiotics with specific emphasis on their potential for early administration in patients at greater risk of SARS-CoV-2 infection. UPDATED
|
|
|
11/30/21
|
Ahn JG | Clin Exp Pediatr
Aim: To discuss epidemiological changes in infectious diseases during the COVID-19 pandemic in Korea.
|
|
|
11/24/21
|
Acuff SF, Strickland JC, Tucker JA, et al. | Psychol Addict Behav
Aim: To examine changes in alcohol consumption during the coronavirus disease (COVID-19) pandemic. UPDATED
|
|
|
11/19/21
|
Talic S, Shah S, Wild H, et al. | BMJ
Aim: To review the evidence on the effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality.
|
|
|
11/16/21
|
Edwards A, Law R, Cooper A | Wales COVID-19 Evidence Centre
Aim: To summarize the current and prospective research studies into Long COVID taking place in Wales.
|
|
|
11/16/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the "test, trace, isolate, and quarantine" strategy advocated by World Health Organization during the COVID-19 pandemic. UPDATED
|
|
|
11/12/21
|
Mccabe G, Sahni DS, Ramsaha S | Indian J Community Med
Aim: To review the efficacy of chloroquine and its derivative hydroxychloroquine in the treatment of COVID-19 and also explores the safety profile of these drugs.
|
|
|
11/12/21
|
Asili P, Mirahmad M, Tabatabaei-Malazy O, et al. | Daru
Aim: To critically report the characteristics of all the registered and published randomized clinical trials (RCTs) conducted on COVID-19, and summarize the evaluation of potential therapies developed in various regions.
|
|
|
11/12/21
|
Puri A, He L, Giri M, et al. | Nurs Open
Aim: To evaluate the comorbidities among severe and non-severe COVID-19 patients in Asian versus non-Asian populations.
|
|
|
11/12/21
|
Panda PK, Sharawat IK, Natarajan V, et al. | J Family Med Prim Care
Aim: To provide a pooled estimate of the efficacy of various medications in children with SARS-CoV-2 infection.
|
|
|
11/12/21
|
Magesh S, John D, Li WT, et al. | JAMA Netw Open
Aim: To evaluate the association of race and ethnicity with COVID-19 outcomes and to examine the association between race, ethnicity, COVID-19 outcomes, and socioeconomic determinants.
|
|
|
11/12/21
|
Navari Y, Bagheri AB, Akhavan Rezayat A, et al. | Health Sci Rep
Aim: To provide a model predictor and a risk analysis of mortality in kidney transplant COVID?19 positive patients.
|
|
|
11/10/21
|
Nindrea RD, Usman E, Katar Y, et al. | Clin Epidemiol Glob Health
Aim: To find the acceptance of COVID-19 vaccination and correlated variables.
|
|
|
11/10/21
|
Rouva G, Vergadi E, Galanakis E | Acta Paediatr
Aim: To evaluate the rate of acute abdomen and abdominal surgical emergencies in children with MIS-C.
|
|
|
11/10/21
|
Varikasuvu SR, Varshney S, Dutt N, et al. | Sci Rep
Aim: To quantify the associations of D-dimer with disease progression in patients with COVID-19.
|
|
|
11/8/21
|
Nejati-Zarnaqi B, Sahebi A, Jahangiri K | J Forensic Legal Med
Aim: To investigate factors affecting the corpse management process of the patients dying of COVID 19.
|
|
|
11/8/21
|
Souza Botelho M, Bolfi F, Leite RGOF, et al. | Syst Rev
Aim: To evaluate the safety of CQ and HCQ from malarial and non-malarial randomized clinical trials (RCTs). UPDATED
|
|
|
11/8/21
|
Sofi F, Dinu M, Reboldi G, et al. | Int J Cardiol
Aim: To investigate whether differences in COVID-19 epidemiology or public health-related factors could explain discrepant findings in different countries. UPDATED
|
|
|
11/5/21
|
Addis A, Amato L, Cruciani F, et al. | Front Pharmacol
Aim: To assess the characteristics of the SoC adopted in the published RCTs.
|
|
|
11/4/21
|
| NSW Health COVID-19 Critical Intelligence Unit
|
|
|
11/4/21
|
| NSW Health COVID-19 Critical Intelligence Unit
|
|
|
11/1/21
|
Amorim dos Santos J, Normando AGC, Carvalho da Silva RL, et al. | J Dent Res
Aim: To provide a comprehensive up-to-date summary of oral manifestations in patients with COVID-19. UPDATED
|
|
|
10/29/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on de-isolation and the risk of infection in people with COVID-19.
|
|
|
10/29/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on adverse foetal and neonatal outcomes associated with COVID-19 infection during pregnancy.
|
|
|
10/29/21
|
Appleton R, Williams J, Vera San Juan N, et al. | J Med Internet Res
Aim: To investigate the adoption and impacts of telemental health approaches during the COVID-19 Pandemic, and facilitators and barriers to optimal implementation. UPDATED
|
|
|
10/22/21
|
Abedi N | J Educ Health Promot
Aim: To investigate the psychological causes and effects of the COVID-19 epidemic outbreak on dentists.
|
|
|
10/22/21
|
Ilonze OJ, Ballut K, Rao RS, et al. | Heart Fail Rev
Aim: To identify the clinical features, outcomes, and immunosuppression strategies of heart transplant recipients with COVID-19 infection.
|
|
|
10/22/21
|
Kreuzberger N, Hirsch C, Chai KL, et al. | Cochrane Database Syst Rev
Aim: To assess the effectiveness and safety of SARS-CoV-2-neutralising mAbs for treating patients with COVID-19, compared to an active comparator, placebo, or no intervention.
|
|
|
10/22/21
|
Tanni SE, Bacha HA, Naime A, et al. | J Bras Pneumol
Aim: To review the evidence on the use of hydroxychloroquine for pre-exposure or post-exposure prophylaxis of SARS-CoV-2 infection and in the treatment of patients with mild COVID-19 in terms of hospitalization, adverse events, and mortality.
|
|
|
10/18/21
|
| CADTH
Aim: To review the evidence on post-COVID-19 condition.
|
|
|
10/15/21
|
| National Collaborating Centre for Methods and Tools
Aim: To review the evidence on the effectiveness, immunogenicity, and safety of COVID-19 vaccines in persons who have had a prior, confirmed COVID-19 infection. UPDATED
|
|
|
10/14/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the use of molnupiravir for the treatment for COVID-19.
|
|
|
10/13/21
|
Ariyo K, Canestrini S, David AS, et al. | BMJ Open
Aim: To explore patient-assessed quality of life (QoL) in ICU survivors before the COVID-19 pandemic. UPDATED
|
|
|
10/12/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the effectiveness of COVID-19 vaccine booster shots.
|
|
|
10/12/21
|
Deal A, Halliday R, Crawshaw AF, et al. | Lancet Infect Dis
Aim: To identify studies on vaccine-preventable disease outbreaks (measles, mumps, rubella, diphtheria, pertussis, polio, hepatitis A, varicella, Neisseria meningitidis , and Haemophilus influenzae ) involving migrants residing in the EU/EEA and Switzerland.
|
|
|
10/12/21
|
Shrestha DB, Budhathoki P, Raut S, et al. | World J Virol
Aim: To analyze the rate of new-onset diabetes in COVID-19 patients and compare their clinical outcomes with those of other COVID-19 patients who had normal or increased blood sugar levels or a pre-existing diagnosis of diabetes. UPDATED
|
|
|
10/8/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the published risk mitigation and models of care for COVID-19 positive people in an acute mental health inpatient unit or in the community.
|
|
|
10/4/21
|
Alsalem MA, Mohammed R, Albahri OS, et al. | Int J Intelligent Syst
Aim: To analyse the rise of MADM techniques in combating COVID-19.
|
|
|
10/1/21
|
Subramaniam A, Antsey C, Curtis JR, et al. | Research Square
Aim: To evaluate the characteristics, and outcomes of frail patients admitted to ICU with COVID-19.
|
|
|
10/1/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the timing of initiation of remdesivir treatment for COVID-19.
|
|
|
10/1/21
|
| Wales COVID-19 Evidence Centre
Aim: To review the evidence on the extent of direct harm from COVID-19 infection and COVID-19 vaccination to pregnant women, those that have recently given birth, and the unborn child.
|
|
|
9/30/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on public health measures to roll out the COVID-19 vaccines.
|
|
|
9/30/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the impact of personal protective equipment (PPE) on therapeutic sessions with adults and children who have experienced domestic or family violence, sexual assault, abuse or neglect.
|
|
|
9/29/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the effect of COVID-19 on children.
|
|
|
9/29/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the use of oxygen saturation monitors in patient homes to detect COVID-19-associated hypoxia.
|
|
|
9/29/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on variable isolation measures for people vaccinated against COVID-19.
|
|
|
9/29/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on available treatments for COVID-19 in pregnant patients.
|
|
|
9/29/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence regarding temporary workforce reconfigurations such as splitting of teams and establishing social distancing protocols within teams to minimise staff exposure to COVID-19.
|
|
|
9/27/21
|
Yin Y, Shi F, Zhang Y, et al. | PLoS One
Aim: To evaluate the reporting quality of randomized controlled trials (RCTs) regarding patients with COVID-19 and analyse the influence factors.
|
|
|
9/24/21
|
Edwards A, Lewis R, Cooper A, et al. | Wales COVID-19 Evidence Centre
Aim: To review the evidence on the effectiveness of non-touch disinfectant methods to reduce the risk of SARS-CoV-2 virus transmission to children and young people in educational settings.
|
|
|
9/20/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on surging the capacity of emergency departments (EDs) during the COVID-19 pandemic.
|
|
|
9/17/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the impact of COVID-19 vaccines on fertility in men and women.
|
|
|
9/17/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on furloughing (leave of absence from work) and self-isolation of healthcare workers following exposure to COVID-19 and the implications for staffing levels.
|
|
|
9/10/21
|
| Health Quality Ontario
Aim: To determine what is known about REGEN-COV (casirivimab and imdevimab) for the treatment of outpatients or inpatients diagnosed with COVID-19.
|
|
|
9/6/21
|
Ferner RE, Aronson JK | Oxford COVID-19 Evidence Service
|
|
|
9/1/21
|
Sharma AP, Sahoo S, Goyal K, et al. | Andrologia
Aim: To determine the presence of SARS?CoV?2 in the semen of men recovering from COVID?19.
|
|
|
9/1/21
|
Tricco A | SPOR Evidence Alliance
Aim: To examine the control and management of COVID-19, SARS, or MERS in adults 60 years or above living in long-term care facilities.
|
|
|
8/30/21
|
Freiberg A, Schubert M, Romero Starke K, et al. | Int J Environ Res Public Health
Aim: To investigate whether COVID-19 lockdown influences modifiable cardiovascular risk factors (i.e., physical inactivity, sedentary behaviour, smoking, alcohol use, unhealthy diet, obesity, bad blood lipids, and hypertension) in the general population.
|
|
|
8/30/21
|
Moothedath M, Muhamood M, Bhosale YS, et al. | J Pharm Bioallied Sci
Aim: To summarize if any of the animal models which are being currently used are turning out to be effective host reservoir.
|
|
|
8/30/21
|
Jena A, Mishra S, Deepak P, et al. | Autoimmune Rev
Aim: To review the evidence on seroconversion after SARS-CoV-2 vaccination in patients with IMIDs and impact of various drugs on seroconversion rates.
|
|
|
8/27/21
|
| NSW Health COVID-19 Critical Intelligence Unit
|
|
|
8/27/21
|
| NSW Health COVID-19 Critical Intelligence Unit
|
|
|
8/27/21
|
| NSW Health COVID-19 Critical Intelligence Unit
|
|
|
8/27/21
|
Picchioni F, Goulao LF, Roberfroid D, et al. | Clin Nutr
Aim: To identify documented effects of COVID-19 on diet quality and nutritional status of children under-5 years and women of childbearing age in LMICs.
|
|
|
8/18/21
|
| NSW Health COVID-19 Critical Intelligence Unit
|
|
|
8/18/21
|
| NSW Health COVID-19 Critical Intelligence Unit
|
|
|
8/17/21
|
Lee M, Lim H, Xavier MS, et al. | J Relig Health
Aim: To summarize the roles that religious communities played during the early stage of COVID-19 pandemic. UPDATED
|
|
|
8/12/21
|
| National Collaborating Centre for Methods and Tools
Aim: To review the evidence on the role of daycares and schools in the transmission of COVID-19. UPDATED
|
|
|
8/6/21
|
Guo S, Yan N, Liu F, et al. | SSRN
Aim: To provide effective exercise interventions for people confined to their homes by social isolation measures during the COVID-19 epidemic, so they can cope with depression timely.
|
|
|
8/5/21
|
Clark M | CADTH
Aim: To review the evidence on the effectiveness of breath tests to detect SARS-CoV-2.
|
|
|
8/5/21
|
Chou R, Dana T, Jungbauer R, et al. | Ann Intern Med
Aim: To examine the effectiveness of N95, surgical, and cloth masks in community and health care settings for preventing respiratory virus infections, and effects of reuse or extended use of N95 masks. UPDATED
|
|
|
8/2/21
|
Mao G, Fernandes-Jesus M, Ntontis E, et al. | BMC Public Health
Aim: To review the evidence on COVID-19 volunteering both at the UK national level and the more local community level.
|
|
|
7/29/21
|
Edwards A, Cooper A, Joseph-Williams N, et al. | Wales COVID-19 Evidence Centre
Aim: To review the evidence on the effectiveness of face coverings in reducing SARS-CoV-2 transmission.
|
|
|
7/28/21
|
Lin C, Lin Y | Arch Clin Psychiatry
Aim: To synthesize the evidence of correlation between demographic factors, social media exposure, stressors and anxiety and depression status in the early phase of COVID-19.
|
|
|
7/28/21
|
Pacheco F, Sobral M, Guiomar R, et al. | Syst Res Behav Sci
Aim: To review evidence regarding the impact of COVID-19 on breastfeeding plans and how these relate to women's psychological outcomes.
|
|
|
7/28/21
|
Akinbi A, Forshaw M, Blinkhorn V | Health Info Sci
Aim: To review the evidence on the current challenges and application of contact tracing apps in the fght against the COVID-19 pandemic.
|
|
|
7/28/21
|
Limongi JE, de Oliviera SV | Vigilância Sanitária em Debate
Aim: To conduct a systematic review of the literature on the application of the concepts of One Health in the current pandemic context of COVID-19.
|
|
|
7/28/21
|
Brabicoski CV, Floriano LMS, Skupien SV, et al. | Braz J Dev
Aim: To review the evidence on the impact of the COVID-19 pandemic on mental health and strategies to cope at the university level.
|
|
|
7/28/21
|
Clark R, Palmer J, Pearce-Smith N, et al. | Public Health England
Aim: To identify and assess direct evidence from the COVID-19 outbreak on the effectiveness of face coverings when used in the community, and the efficacy of different types of face coverings.
|
|
|
7/28/21
|
Orsini MA, do Nascimento JSF, Azizi M, et al. | Revista de Saúde
Aim: To review the evidence on the effects of the pandemic on sleep disorders, with insomnia being the most related.
|
|
|
7/28/21
|
Popp M, Stegemann M, Metzendorf M, et al. | Cochrane Database Syst Rev
Aim: To assess the efficacy and safety of ivermectin compared to no treatment, standard of care, placebo, or any other proven intervention for people with COVID?19 receiving treatment as inpatients or outpatients, and for prevention of an infection with SARS?CoV?2 (postexposure prophylaxis).
|
|
|
7/27/21
|
Fan KS, Ghani SA, Machairas N, et al. | BMJ Open
Aim: To assess the quality of information of top indexed websites that discuss information, prevention or treatment of COVID-19.
|
|
|
7/26/21
|
Timbrook TT, Hueth KD, Ginocchio CC | Diagn Microbil Infect Dis
Aim: To review the evidence on the impact of BioFire® FilmArray® Pneumonia Panel in detecting bacteria and clinical management among critically ill COVID-19 patients admitted to the ICU.
|
|
|
7/26/21
|
Agrati C, Sacchi A, Tartaglia E, et al. | Int J Mol Sci
Aim: To describe the current state of knowledge about P-selectin involvement in COVID-19 pathogenesis, its possible use as a severity marker and as a target for host-directed therapeutic intervention.
|
|
|
7/24/21
|
Kermani-Alghoraishi M, Pouramini A, Kafi F, et al. | Curr Probl Cardiol
Aim: To review the reports of moderate to severe pericardial effusion associated with tamponade physiology.
|
|
|
7/21/21
|
Edwards A, Cooper A, Joseph-Williams N, et al. | Wales COVID-19 Evidence Centre
Aim: To review the evidence on the mental health of health and social care workers in UK settings during the COVID-19 pandemic.
|
|
|
7/16/21
|
Franceschi VB, Santos AS, Glaeser AB, et al. | Rev Med Virol
Aim: To evaluate the qualitative aspects of population-based seroprevalence surveys of COVID-19, including their reliability and biases. UPDATED
|
|
|
7/16/21
|
Agarwal L, Agarwal A, Advani S, et al. | BR J Radiol
Aim: To scope the existing literature on the abdominal imaging findings in COVID-19. UPDATED
|
|
|
7/15/21
|
| EUnetHTA
Aim: To review the evidence on the use of anakinra for the treatment for COVID-19. UPDATED
|
|
|
7/15/21
|
| EUnetHTA
Aim: To review the evidence on the use of APN01 for the treatment for COVID-19. UPDATED
|
|
|
7/15/21
|
| EUnetHTA
Aim: To review the evidence on the use of aspirin for the treatment for COVID-19. UPDATED
|
|
|
7/15/21
|
| EUnetHTA
Aim: To review the evidence on the use of baricitinib for the treatment for COVID-19. UPDATED
|
|
|
7/15/21
|
| EUnetHTA
Aim: To review the evidence on the use of camostat for the treatment for COVID-19. UPDATED
|
|
|
7/15/21
|
| EUnetHTA
Aim: To review the evidence on the use of ivermectin for the treatment for COVID-19. UPDATED
|
|
|
7/9/21
|
Abou-Setta AM, Lam O, Kasireddy V, et al. | SPOR Evidence Alliance
Aim: To review the evidence on the rate of pregnant persons admitted to the ICU/developing severe COVID outcomes.
|
|
|
7/8/21
|
Sharma A, Ghosh D, Divekar N, et al. | Int Soc Sci J
Aim: To compare and assess the socio?economic implications of the 1918 influenza pandemic and the COVID?19 pandemic in India.
|
|
|
7/8/21
|
Egunsola O, Mastikhina L, Dowsett L, et al. | SPOR
Aim: To identify comparative observational studies and randomized controlled trials (RCTs) evaluating the effectiveness or efficacy of COVID-19 vaccination in reducing infection transmission, asymptomatic viral carriage and other proxies of possible transmission, such as cycle threshold (Ct) values and viral load. UPDATED
|
|
|
7/6/21
|
Wang YY, Huang Q, Shen Q, et al. | Front Med
Aim: To assess the quality of relevant COVID-19 clinical practice guidelines (CPGs) and to compare the similarities and differences between recommendations.
|
|
|
7/5/21
|
Rebi? N, Park J, Garg R, et al. | Arthritis Care Res
Aim: To identify, appraise, synthesize, and contextualize rapidly emerging reports on medication taking ('adherence') among patients with rheumatic diseases during the COVID-19 pandemic.
|
|
|
7/2/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the best practice management of a COVID-19 neonate.
|
|
|
7/1/21
|
Liu K, Yang T, Peng XF, et al. | Rev Med Virol
Aim: To identify the immune signatures that better distinguish the development of COVID?19 outcome.
|
|
|
7/1/21
|
Alhasan M, Hasaneen M | Comput Med Imaging Graph
Aim: To explore the trends of modern healthcare technologies and Artificial Intelligence (AI) during COVID-19 crisis.
|
|
|
6/30/21
|
O'Sullivan L, Killeen RP, Doran P, et al. | BMC Med Ethics
Aim: To determine whether COVID-19 human research publications report compliance with ethical safeguards.
|
|
|
6/28/21
|
| National Collaborating Centre for Methods and Tools
Aim: To review the evidence on parents' considerations for vaccine uptake for children and adolescents.
|
|
|
6/25/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the effectiveness of face masks at preventing COVID-19 transmission when the wearer has facial hair.
|
|
|
6/25/21
|
| SPOR
Aim: To identify scientific evidence on surveillance and testing approaches to monitor the presence of the virus in a vaccinated population and determine how these influence testing strategies.
|
|
|
6/24/21
|
Brurberg KG, Himmels JPW | Norwegian Institute of Public Health
Aim: To review the evidence on the risk of COVID-19 infection among people with immigrant backgrounds.
|
|
|
6/22/21
|
| Health Information and Quality Authority
Aim: To identify the risk of COVID-19 re-infection over time.
|
|
|
6/18/21
|
Mitton C, Smith N, Lakzadeh P, et al. | SPOR Evidence Alliance
Aim: To review the evidence on rapid diagnostic testing (RDT) for COVID-19 in a fully vaccinated population.
|
|
|
6/15/21
|
Das P, Mondal S, Pal S, et al. | Indian J Med Microbiol
Aim: To review the evidence on nucleic acid based testing systems for COVID-19.
|
|
|
6/15/21
|
| McMaster University Health Forum
Aim: To review the evidence on the effectiveness of the COVID-19 response in Canada.
|
|
|
6/11/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence of fit testing and fit checking for testing the protection of a respirator and the factors that influence the outcomes of fit testing.
|
|
|
6/9/21
|
Rodríguez PG, Agapito BP, Rodríguez MSA, et al. | An Pediatr
Aim: To summarize a critical appraisal document of the available evidence on COVID-19, developed with a clinical practice guide format following GRADE methodology.
|
|
|
6/9/21
|
Liu DT, Philips KM, Speth MM, et al. | Otolaryngol Head Neck Surg
Aim: To summarize the current state of knowledge on portable high-efficiency particulate air (HEPA) purifiers' effectiveness in eliminating airborne SARS-CoV-2 from indoor environments.
|
|
|
6/9/21
|
Moghadasi AN, Mirmosayyeb O, Barzegar M, et al. | Neurol Sci
Aim: To estimate the pooled prevalence of COVID-19 in patients with MS.
|
|
|
6/7/21
|
Nascimento I, O Mathuna DP, von Groote TC, et al. | BMC Infect Med
Aim: To collate and summarize all published systematic reviews on the coronavirus disease (COVID-19). UPDATED
|
|
|
6/7/21
|
Salah G, Ahmed A, Hassanain O, et al. | Nutr Cancer
Aim: To understand the role of nutrition in cancer patients during Corvid 19 era.
|
|
|
6/7/21
|
Ao G, Wang Y, Qi X, et al. | Transplant Rev
Aim: To investigate the association between severe or fatal COVID-19 and SOT. UPDATED
|
|
|
6/3/21
|
| Health Information and Quality Authority
Aim: To review the international policies and guidelines relating to healthcare personnel who do not avail of COVID-19 vaccination.
|
|
|
6/3/21
|
Kelly SE, Wells GA | SPOR Evidence Alliance
Aim: To review the evidence on point-of-care diagnostic tools for SARS-CoV-2.
|
|
|
6/2/21
|
| CReSP
Aim: To review the evidence on the impact of redeployment of expertise and public health services towards the COVID-19 pandemic response.
|
|
|
6/2/21
|
Wilt T, Kaka AS, MacDonald R, et al. | VA Evidence Synthesis Program
Aim: To assess the clinical effectiveness and harms of remdesivir in hospitalized adults with COVID-19. UPDATED VA ESP
|
|
|
6/2/21
|
Patnaik N, Bhatia V, Mishra KG, et al. | J Family Med Prim Care
Aim: To analyse symptoms of pregnant women affected with COVID-19.
|
|
|
6/2/21
|
| National Collaborating Centre for Methods and Tools
Aim: To review the evidence on the prevalence of household food insecurity in North America as a result of the COVID-19 and associated public health measures.
|
|
|
6/1/21
|
Hempel S, Burke RV, Hochman M, et al. | J Clin Epidemiol
Aim: To review evidence-based approaches for evaluation of strategies for policymakers.
|
|
|
6/1/21
|
Chou R, Dana T, Buckley D, et al. | Ann Intern Med
Aim: To examine the burden of SARS-CoV-2, SARS-CoV-1, and Middle Eastern respiratory syndrome (MERS)-CoV on HCWs and risk factors for infection, using rapid and living review methods. UPDATED WHO COLLABORATIVE
|
|
|
6/1/21
|
Bahji A, Danilewitz M, Crockford D | Can J Addiction
Aim: To review existing COVID-19 guidelines for PWUD to synthesize evidence and identify consensus and disagreement areas.
|
|
|
6/1/21
|
| Wales COVID-19 Evidence Centre
Aim: To review the evidence on barriers to, and facilitators of vaccination uptake in adults who are underserved or hard-to-reach.
|
|
|
5/31/21
|
| EUnetHTA
Aim: To review the evidence on the use of darunavir for the treatment for COVID-19.
|
|
|
5/31/21
|
| EUnetHTA
Aim: To review the evidence on the use of favipiravir for the treatment for COVID-19.
|
|
|
5/27/21
|
| Saskatchewan Health Authority
Aim: To review the evidence on what other jurisdictions are offering for incentive-based COVID-19 vaccine campaigns.
|
|
|
5/21/21
|
O'Leary N, Kingston L, Griffin A, et al. | Scand J Public Health
Aim: To document the healthcare policies developed during the initial wave of widespread COVID-19 transmission in Ireland.
|
|
|
5/20/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on COVID-19 vaccination before elective surgery, including any recommendations regarding the timing of vaccination.
|
|
|
5/20/21
|
Hampson G, Stone M, Lindsay JR, et al. | Calcif Tissue Int
Aim: To provide information on how the COVID-19 pandemic has impacted the diagnosis and management of osteoporosis.
|
|
|
5/20/21
|
Saulle R, Minozzi S, Amato L, et al. | Recenti Prog Med
Aim: To summarize the most relevant data from a literature systematic review on the impact on youths' physical health of the 2020 school closure and social distances measures implemented in response to COVID-19 pandemic.
|
|
|
5/19/21
|
Campbell H, Wood AC | Curr Nutr Rep
Aim: To examine the evidence that the dietary quality of children changed between the period preceding the COVID-19 pandemic and the first year during the pandemic.
|
|
|
5/19/21
|
Himmels JPW, Borge TC, Brurberg KG, et al. | Norwegian Institute of Public Health
Aim: To review the evidence on the risk factors for severe COVID-19 disease.
|
|
|
5/18/21
|
| EUnetHTA
Aim: To review the evidence on the use of interferon and novaferon for the treatment for COVID-19.
|
|
|
5/18/21
|
| EUnetHTA
Aim: To review the evidence on the use of sarilumab for the treatment for COVID-19.
|
|
|
5/17/21
|
| CADTH
Aim: To review the evidence on the availability, accuracy, safety, cost, and other considerations for using self-administered screening tests at home for severe acute respiratory syndrome coronavirus 2, or SARS-CoV-2.
|
|
|
5/17/21
|
| EUnetHTA
Aim: To review the evidence on the use of canakinumab for the treatment for COVID-19.
|
|
|
5/17/21
|
| EUnetHTA
Aim: To review the evidence on the use of convalescent plasma treatment for COVID-19.
|
|
|
5/17/21
|
Gebreheat G, Teame H | J Multidiscip Healthc
Aim: To identify the main ethical challenges faced by nurses during COVID-19 pandemic.
|
|
|
5/17/21
|
| EUnetHTA
Aim: To review the evidence on the use of gimsilumab for the treatment for COVID-19.
|
|
|
5/17/21
|
| EUnetHTA
Aim: To review the evidence on the use of high-dose vitamin D for the treatment for COVID-19.
|
|
|
5/17/21
|
Lei H, Yang Y, Zhou W, et al. | Lung Cancer
Aim: To provide precise estimates of the mortality rate of COVID-19 patients with lung cancer and other tumors. UPDATED
|
|
|
5/17/21
|
| EUnetHTA
Aim: To review the evidence on the use of mavrilimumab for the treatment for COVID-19.
|
|
|
5/17/21
|
| EUnetHTA
Aim: To review the evidence on the use of molnupiravir for the treatment for COVID-19.
|
|
|
5/17/21
|
| EUnetHTA
Aim: To review the evidence on the use of nafamostat for the treatment for COVID-19.
|
|
|
5/17/21
|
El-Menyar A, Mekkodathil A, Asim M, et al. | Sci Prog
Aim: To explore the standards for research conduction, publications and retraction of articles related to COVID-19 pharmacotherapy research during the pandemic.
|
|
|
5/17/21
|
| EUnetHTA
Aim: To review the evidence on the use of solnatide for the treatment for COVID-19.
|
|
|
5/17/21
|
| EUnetHTA
Aim: To review the evidence on the use of tocilizumab for the treatment for COVID-19.
|
|
|
5/14/21
|
Antwi HA, Zhou L, Xu X, et al. | Healthcare
Aim: To examine the extent to which companies are able to balance their business interest with social interest through health-related CSR and how knowledge of them can help explain the potential impact of COVID-19.
|
|
|
5/12/21
|
Lin Z, Chen J, Han S | Expert Rev Anticancer Ther
Aim: To assess whether anti-cancer therapies such as surgery, chemotherapy, immunotherapy, and targeted therapy will increase the severity and mortality of cancer patients with COVID-19.
|
|
|
5/12/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on vaccine hesitancy.
|
|
|
5/11/21
|
Lim XY, Chan JCW, Tan TYC, et al. | Natural Product Com
Aim: To collate and analyze the antiviral evidence for A. paniculata, andrographolide, and its analogs, specifically against SARS-CoV-2.
|
|
|
5/7/21
|
Rosenberger KJ, Xu C, Lin L | J Eval Clin Pract
Aim: To methodologically assess the current systematic reviews and meta-analyses on COVID-19.
|
|
|
5/3/21
|
Peixoto AO, Costa RM, Uzun R, et al. | Pulmonology
Aim: To review the evidence on the use of lung ultrasound in COVID-19.
|
|
|
5/3/21
|
Pb S, Mittal S, Madan K, et al. | Monaldi Arch Chest Dis
Aim: To evaluate the available evidence and performed meta-analysis of the effect of awake PP in non-intubated patients on improvement in oxygenation and reducing the need for intubation.
|
|
|
5/3/21
|
Siegel A, Zuo Y, Moghaddamcharkari N, et al. | Curr Opin Psychiatry
Aim: To synthesize the extant literature reporting on barriers of telemental health (TMH) during the COVID-19 pandemic and how facilities have worked to overcome these barriers, to inform best practices for TMH delivery.
|
|
|
5/3/21
|
Neira C, Godinho R, Rincon F, et al. | Nutrients
Aim: To evaluate the current evidence about the impact that preventive measures of physical contact restriction causes in healthy nutrition. UPDATED
|
|
|
5/3/21
|
Gianfredi V, Mauer NS, Gentile L, et al. | Int J Environ Res Public Health
Aim: To evaluate the available scientific evidence on the risks of recreational skiing for the evolution of the COVID-19 pandemic.
|
|
|
5/3/21
|
Corrao S, Mallaci Bocchio R, Lo Monaco M, et al. | Nutrients
Aim: To analyze the current knowledge from systematic reviews of the relationship between nutraceutical supports and the reduction in inflammatory response to formulate clinical recommendations and highlight directions for future research during the COVID-19 pandemic.
|
|
|
5/3/21
|
Nobari H, Fashi M, Eskandari A, et al. | Int J Environ Res Public Health
Aim: To assess and provide an up-to-date analysis of the impact of coronavirus disease 2019 (COVID-19) pandemic on the health-related quality of life (HRQoL) of children and adolescents.
|
|
|
5/3/21
|
Regmi K, Lwin CM | Int J Environ Res Public Health
Aim: To review the factors associated with the implementation of NPIs (social distancing, social isolation and quarantine) for reducing COVID-19.
|
|
|
5/3/21
|
La Verde M, Riemma G, Torella M, et al. | Int J Gynaecol Obstet
Aim: To evaluate the characteristics of pregnant women deceased due to COVID-19. UPDATED
|
|
|
5/3/21
|
Putri C, Hariyanto TI, Hananto JE, et al. | Parkinsonism Relat Disord
Aim: To analyze the relationship between PD and in-hospital outcomes of COVID-19.
|
|
|
5/3/21
|
Diaz-Arocutipa C, Saucedo-Chinchay J, Imazio M, et al. | J Cardiovasc Med
Aim: To summarize the clinical features, diagnostic methods, treatment, and outcomes of coronavirus disease 2019 (COVID-19) patients with pericarditis.
|
|
|
5/3/21
|
Ponnapa Reddy M, Subramaniam A, et al. | Crit Care Med
Aim: To evaluate the impact of prone positioning on oxygenation and clinical outcomes.
|
|
|
5/3/21
|
Mojahed A, Brym S, Hense H, et al. | Front Psychiatry
Aim: To review the evidence on the context of social and geographical isolation and their associations with intimate partner violence.
|
|
|
5/3/21
|
Dramé M, Cofais C, Hentzien M, et al. | Nutrients
Aim: To identify and synthesize the best available evidence on the association between vitamin D level and risk of COVID-19, adverse outcomes and possible benefits of supplementation aged 60 years or over. UPDATED
|
|
|
5/3/21
|
Magnavita N, Chirico F, Garbarino S, et al. | Int J Environ Res Public Health
Aim: To summarize and combine relevant data from existing systematic reviews and meta-analyses in order to evaluate the association of coronaviruses (SARS, MERS, SARS-CoV-2) with BOS in HCWs.
|
|
|
5/3/21
|
Hasan T, Beardsley J, Marais BJ, et al. | Vaccines
Aim: To assess the publicly-available policies and implementation strategies used for COVID-19 mass vaccination.
|
|
|
5/3/21
|
Bareille M, Hardy M, Douxfils J, et al. | J Clin Med
Aim: To assess the potential usefulness of viscoelastometric testing (VET) to predict thrombotic events in COVID-19 patients.
|
|
|
4/30/21
|
| NSW Health COVID-19 Critical Intelligence Unit
|
|
|
4/30/21
|
| NSW Health COVID-19 Critical Intelligence Unit
|
|
|
4/30/21
|
Crawshaw J, Konnyu K, Castillo G, et al. | The Ottawa Hospital Research Institute
Aim: To review the evidence on how behavioural science can help inform messaging to and broader supports for the general public to encourage vaccination for COVID-19.
|
|
|
4/30/21
|
Blum P, Putzer D, Liebensteiner MC, et al. | In Vivo
Aim: To provide a systematic review of the published literature on the impact by the Covid-19 pandemic on orthopaedic and traumatological care by focusing on the number of clinical visits, surgeries and reasons for consultation.
|
|
|
4/30/21
|
| National Collaborating Centre for Methods and Tools
Aim: To review the evidence on what is known about reasons for vaccine confidence and uptake in populations experiencing inequities.
|
|
|
4/29/21
|
Córdova LDS, Vega APM, Luján-Carpio E, et al. | Dement Neuropsychol
Aim: To describe the characteristics of COVID-19 patients, both over and under 80 years old, by conducting a systematic review of the literature describing case reports, and to summarize and critically assess these characteristics.
|
|
|
4/29/21
|
Vist GE, Arentz-Hansen EH, Vedoy TF, et al. | Norwegian Institute of Public Health
Aim: To summarize and assess available research from Norway and countries with similar welfare systems on the incidence of infection, rate of admission to hospital and death due to COVID-19.
|
|
|
4/29/21
|
Schlesinger S, Neuenschwander M, Lang A, et al. | Diabetologia
Aim: To identify high-risk phenotypes of diabetes associated with COVID-19 severity and death.
|
|
|
4/29/21
|
Rogers JP, Chesney E, Oliver D, et al. | Epidemiol Psychiatr Sci
Aim: To establish whether infectious epidemics are associated with any changes in the incidence of suicide or the period prevalence of self-harm, or thoughts of suicide or self-harm, with a secondary objective of establishing the frequency of these outcomes.
|
|
|
4/28/21
|
Ren X, Ren X, Lou J, et al. | EClinicalMedicine
Aim: To comprehensively analyze the COVID-19 patients with RP RT-PCR result after discharged through the inclusion of extensive relevant studies; focus on the clinical characteristics, the possible causes and risk factors.
|
|
|
4/28/21
|
Anti-interleukin-6 therapies for Covid-19: A systematic review, critical appraisal and meta-analysis
Elavarasi A, Sahoo RK, Seth T, et al. | Natl Med J India
Aim: To review the evidence on anti-IL-6 therapies in the treatment of COVID-19.
|
|
|
4/28/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on COVID-19 vaccination for immunocompromised patients including risks and adverse events, efficacy and advice from professional colleges.
|
|
|
4/28/21
|
Bartoszko JJ, Siemieniuk RAC, Kum E, et al. | BMJ
Aim: To determine and compare the effects of drug prophylaxis on severe acute respiratory syndrome coronavirus virus 2 (SARS-CoV-2) infection and coronavirus disease 2019 (covid-19). UPDATED
|
|
|
4/27/21
|
Mackey K, Kansagara D, Vela K | Ann Intern Med
Aim: To synthesize evidence on the role of ACE inhibitor and ARB use on patient outcomes in COVID-19 as well as evidence on the benefits and harms of initiating these medications to treat patients with COVID-19. UPDATED WHO COLLABORATIVE VA ESP
|
|
|
4/19/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the efficacy of rapid, point-of-care tests for COVID-19.
|
|
|
4/15/21
|
De Armond M, Feliciano S, Hirabayashi E, et al. | JBI Evid Synth
|
|
|
4/15/21
|
Chew NW, Ow ZGW, Teo VXY, et al. | Can J Cardiol
Aim: To examine the global impact of COVID-19 pandemic on incidence of STEMI admissions, and relationship between the pandemic and door-to-balloon time (D2B), all-cause mortality and other secondary STEMI outcomes.
|
|
|
4/14/21
|
Sohrabizadeh S, Yousefian S, Bahramzadeh A, et al. | BMC Public Health
Aim: To identify the literature focused on health system response to coincidence of COVID-19 and disasters as well as describing their finding, implications and lessons-learned.
|
|
|
4/13/21
|
| NSW Health COVID-19 Critical Intelligence Unit
|
|
|
4/12/21
|
Meza N, Perez-Bracchiglione J, Perez I, et al. | Medwave
Aim: To provide a timely, rigorous, and continuously updated summary of the evidence available on the role of angiotensin-converting enzyme inhibitors (ACEi) and angiotensin II receptor blockers (ARB) in the treatment of patients with COVID-19. UPDATED
|
|
|
4/12/21
|
Fonhus MS, Dalsbo TK, Brurberg KG | Norwegian Institute of Public Health
Aim: To analyse and summarise the effectiveness of facemasks on respiratory virus transmission, such as COVID-19.
|
|
|
4/12/21
|
Nguyen T, Buxton JA | Int J Drug Policy
Aim: To review the evidence on the unintended pathways between COVID-19 public health responses and increasing illicit drug overdoses.
|
|
|
4/8/21
|
Medina C, Chavira J, Aburto T, et al. | Salud Publica de Mexico
Aim: To describe the available evidence on the transmission of Covid-19 or similar acute respiratory infections in open, public spaces.
|
|
|
4/5/21
|
Li YC, Lai T, Lin S, et al. | Ther Adv Chronic Dis
Aim: To evaluate the influence of pre-existing CKD on risks of all-cause mortality, hospitalization, and critically ill condition among patients with COVID-19 infection. UPDATED
|
|
|
4/2/21
|
Zhao M, Zhao C, Tu S, et al. | J Integr Med
Aim: To assess the methodological quality and variability in implementation of randomized controlled trials (RCTs) for treating COVID-19, and to analyze the support that should be provided to improve data collected during an urgent pandemic situation.
|
|
|
4/1/21
|
Hilal N, Shaya R, Hamadeh R, et al. | Knowledge to Policy (K2P) Center
Aim: To review the evidence on the integration of COVID-19 vaccination into the services delivered by the National Primary Health Care network in Lebanon.
|
|
|
3/31/21
|
| Health Information and Quality Authority
Aim: To explore potential populations for consideration in vaccine allocation group nine based on national and international evidence for the risk of infection, and risk of severe disease, with COVID-19.
|
|
|
3/31/21
|
Crawshaw J, Castillo G, Grimshaw J, et al. | The Ottawa Hospital Research Institute
Aim: To review the evidence on how behavioural science can help inform messaging to and broader supports for healthcare workers to encourage vaccination for COVID-19?
|
|
|
3/29/21
|
Tuite AR, Fisman DN, Odutayo A, et al. | Ontario COVID-19 Science Advisory Table
Aim: What are the risks of COVID-19 hospitalization, ICU admission and death caused by VOCs as compared with the early variants of SARS-CoV-2?
|
|
|
3/29/21
|
Brolin K, Cenciarelli O, Colzani E, et al. | European Centre for Disease Prevention and Control
Aim: To provide a summary of the available scientific evidence on the risk of SARS-CoV-2 transmission to susceptible contacts from infected individuals with documented previous infection or vaccination.
|
|
|
3/25/21
|
| CADTH
|
|
|
3/25/21
|
| Pan American Health Organization
Aim: To review the evidence on potential COVID-19 therapeutics.
|
|
|
3/23/21
|
Kain D, Stall NM, Allen V, et al. | Science Table COVID-19 Advisory for Ontario
Aim: To review the evidence on routine asymptomatic screen testing of staff as a potential mitigating strategy to reduce SARS-CoV-2 introduction and transmission in LTC homes.
|
|
|
3/23/21
|
Ryan RE, Parkhill A, Schonfeld L, et al. | Health Evidence Network
Aim: To analyse evidence regarding communication with individuals and communities within the wider structural and sociopolitical context of the pandemic to support public health decision-makers when planning and implementing physical distancing measures. WHO COLLABORATIVE
|
|
|
3/17/21
|
| NSW Health COVID-19 Critical Intelligence Unit
|
|
|
3/17/21
|
| NSW Health COVID-19 Critical Intelligence Unit
|
|
|
3/17/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the AstraZeneca vaccine and blood clots.
|
|
|
3/17/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidenceo n the likelihood that SARS-CoV-2 will become endemic.
|
|
|
3/16/21
|
Meena JP, Gupta AK, Tanwar P, et al. | Pediatr Blood Cancer
Aim: To review the evidence on pediatric cancer patients affected by COVID-19 and analyze the clinical manifestations and outcomes. UPDATED
|
|
|
3/16/21
|
Munich J, Dennett L, Swainson J, et al. | Front Psychiatry
Aim: To rapidly synthesize available data on emergency department utilization for psychiatric concerns during COVID-19.
|
|
|
3/16/21
|
Helvaci N, Eyupoglu ND, Karabulut E, et al. | Front Endocrinol
Aim: To evaluate the prevalence of obesity in patients with COVID-19 and to stratify the estimates by illness severity. UPDATED
|
|
|
3/16/21
|
Hossain A, Nasrullah SM, Tasnim Z, et al. | EClinicalMedicine
Aim: To estimate pooled seroprevalence of SARS-CoV-2 IgG antibodies across geographic regions and to investigate the pattern by age-group, gender, infection risk of HCWs, and study period. UPDATED
|
|
|
3/15/21
|
Mehta AA, Haridas N, Belgundi P, et al. | Diabetes Metab Syndr
Aim: To provide a comprehensive summary of clinical and laboratory parameters that are associated with and indicative of increased severity among COVID-19 patients.
|
|
|
3/15/21
|
Marzoli F, Bortolami A, Pezzuto A, et al. | Sci Total Environ
Aim: To summarize all the evidence on surface survival of coronaviruses infecting humans.
|
|
|
3/15/21
|
Lim ZJ, Reddy MP, Curtis JR, et al. | Crit Care Med
Aim: To investigate the incidence, characteristics, and outcomes of in-hospital cardiac arrest in patients with coronavirus disease 2019 and to describe the characteristics and outcomes for patients with in-hospital cardiac arrest within the ICU, compared with non-ICU patients with in-hospital cardiac arrest. UPDATED
|
|
|
3/15/21
|
Huntley B, Mulder IA, Di Mascio D, et al. | Obstet Gynecol
Aim: To compare the risk of intrauterine fetal death (20 weeks of gestation or later) and neonatal death among individuals who tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) compared with those who tested negative for SARS-CoV-2 on admission for delivery. UPDATED
|
|
|
3/15/21
|
Karimian M, Azami M | Pol J Radiol
Aim: To evaluate CT scan findings of COVID-19 at the time of admission. UPDATED
|
|
|
3/15/21
|
Yang Y, Sun S, Hu S, et al. | Front Psychol
Aim: To compare the different psychological interventions and distinguish the most effective way to treat psychological crisis according to different clinical manifestations in people affected by coronavirus disease 2019 (COVID-19).
|
|
|
3/15/21
|
Zhang X, Xi L, Pang F, et al. | Iran J Public Health
Aim: To summarize the clinical evidence regarding the efficacy and safety of convalescent plasma therapy in the treatment of severe COVID-19.
|
|
|
3/15/21
|
Qiang Z, Wang B, Garrett BC, et al. | Curr Opin Cardiol
Aim: To have a greater mortality impact on subgroups of people in the population who are deemed to be at higher medical disease risk.
|
|
|
3/15/21
|
Pranata R, Huang I, Lim MA, et al. | Arch Gerontol Geriatr
Aim: To establish the association between delirium and mortality in older adults with COVID-19. UPDATED
|
|
|
3/15/21
|
Xing K, Tu X, Liu M, et al. | Zhongguo Dang Dai Er Ke Za Zhi
Aim: To evaluate systematically the efficacy and safety of COVID-19 vaccines.
|
|
|
3/15/21
|
Abate SM, Checkol YA, Mantefardo B | Ann Med Surg
Aim: To provide global evidence on the prevalence and risk factors including age, gender, comorbidity, and substance use on hospital mortality among hospitalized patients with COVID-19.
|
|
|
3/15/21
|
Syahrul S, Maliga HA, Ilmawan M, et al. | F1000Research
Aim: To determine the global prevalence, chronological order of symptom appearance, and mortality rates with regard to hemorrhagic and ischemic stroke in patients with coronavirus disease 2019 (COVID-19) and to discuss possible pathogeneses of hemorrhagic and ischemic stroke in individuals with the disease. UPDATED
|
|
|
3/15/21
|
Yuan J, Qian H, Cao S, et al. | Transl Pediatr
Aim: To investigate the clinical features of pregnant women and their neonates with coronavirus disease 2019 (COVID-19) and the evidence of vertical transmission of COVID-19.
|
|
|
3/15/21
|
Moran C, Campbell DJT, Campbell TS, et al. | J Public Health
Aim: To identify predictors of attitudes toward and adherence to COVID-19 public health guidelines, and identify interventions aiming to improve adherence.
|
|
|
3/15/21
|
Alene M, Yismaw L, Assemie MA, et al. | BMC Infect Dis
Aim: To determine the overall pooled mean serial interval and incubation period of COVID-19 using available evidences.
|
|
|
3/15/21
|
Dorward J, Gbinigie O, Cai T, et al. | Antivir Ther
Aim: To synthesise the clinical evidence for lopinavir/ritonavir as a treatment for COVID-19.
|
|
|
3/15/21
|
Stanoeva KR, van der Eijk AA, Meijer A, et al. | Euro Surveill
Aim: To review current published knowledge on the kinetics of SARS-CoV-2 infection as assessed by RNA molecular detection in a wide range of clinical samples.
|
|
|
3/11/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the effectiveness of the AstraZeneca vaccine, particuarly regarding hospitalisations in the United Kingdom.
|
|
|
3/8/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the impact of the COVID-19 pandemic on the publication of pre-peer review articles and the quality of research evidence.
|
|
|
3/8/21
|
Skapetis T, Law C, Rodricks R, et al. | BMC Med Ethics
Aim: To determine the ethical challenges associated with conducting medical research in low COVID-19 prevalence countries.
|
|
|
3/5/21
|
| National Collaborating Centre for Methods and Tools
Aim: To review the evidence on how long the COVID-19 virus can survive with potential for infection on surfaces found in community settings.
|
|
|
3/4/21
|
Park JY, Freer R, Stevens R, et al. | Oxford COVID-19 Evidence Service
|
|
|
3/3/21
|
Himmels JPW, Qureshi SA, Brurberg KG, et al. | Norwegian Institute of Public Health
Aim: To review the evidence on the possible long-term effects of COVID-19, including long COVID.
|
|
|
3/1/21
|
Gupta N, Balcom S, Gulliver A, et al. | Int J Health Planning Manag
Aim: To assess the state of the evidence on policy and planning responses to HRH surge capacity during the coronavirus disease (COVID?19) pandemic and other viral respiratory disease outbreaks of global significance in the 21st century. UPDATED
|
|
|
3/1/21
|
Morris AM, Stall NM, Bobos P, et al. | Ontario COVID-19 Science Advisory Table
Aim: Does tocilizumab improve patient outcomes such as mortality, need for mechanical ventilation, requirement for organ support, intensive care unit (ICU) length of stay, and hospital length of stay for individuals hospitalized with COVID-19?
|
|
|
2/28/21
|
| Penn Medicine’s Center for Evidence-based Practice
Aim: To identify pathways, algorithms, and clinical risk prediction tools that can be used in Emergency Department triage of patients with suspected or confirmed COVID-19 disease and to review the evidence on their effectiveness.
|
|
|
2/25/21
|
Schiff JW | CMH Initiative
|
|
|
2/23/21
|
| CADTH
Aim: To review the evidence on tocilizumab and sarilumab for their potential use in managing COVID-19.
|
|
|
2/22/21
|
Puyat JH, Ahmad H, Kazanjian H | CMH Initiative
Aim: To investigate home-based activities that have protective and therapeutic effects against mental health symptoms during pandemics and to identify if there are activities that are effective for specific groups.
|
|
|
2/19/21
|
Dotto L, de Azevedo Kinalski M, Machado PS, et al. | J Evid Based Med
Aim: To assess the characteristics of different designs of systematic reviews (SRs) registered in the International Prospective Register of Systematic Reviews (PROSPERO) about COVID-19.
|
|
|
2/17/21
|
Kumar D, Severn M | CADTH
|
|
|
2/16/21
|
Labad J, Gonzalez-Rodriguez A, Cobo J, et al. | PeerJ
Aim: To explore whether the coronavirus disease 2019 (COVID-19) pandemic is associated with toilet paper hoarding and to assess which risk factors are associated with the risk of toilet paper hoarding. UPDATED
|
|
|
2/16/21
|
Sarria-Guzman Y, Fusaro C, Bernal JE, et al. | J Infect Dev Ctries
Aim: To identify and to evaluate the reports associated on Knowledge, Attitude and Practices (KAP) towards COVID-19 pandemic in America.
|
|
|
2/15/21
|
| EUnetHTA
Aim: To review the evidence on the use of bamlanivimab for the treatment for COVID-19.
|
|
|
2/15/21
|
| EUnetHTA
Aim: To review the evidence on the use of casirivimab for the treatment for COVID-19.
|
|
|
2/13/21
|
Chowdhury P, Paul SK, Kaisar S, et al. | Transp Rep E Logist Transp Rev
Aim: To systematically review existing research on the COVID-19 pandemic in supply chain disciplines.
|
|
|
2/11/21
|
Bauer M, Groesdonk HV, Preissing F, et al. | Anaesthesist
Aim: To estimate 30-day and 90-day mortality of patients with sepsis and patients with septic shock in Germany and to compare the mortality with that of other industrialized regions (Europe, North America).
|
|
|
2/10/21
|
| NSW Health COVID-19 Critical Intelligence Unit
|
|
|
2/8/21
|
Dabone C, Mbagwu I, Muray M, et al. | J Racial Ethn Health Disparities
Aim: To assess the food insecurity conditions of ACB populations globally during the COVID-19 pandemic.
|
|
|
2/8/21
|
| NSW Health COVID-19 Critical Intelligence Unit
|
|
|
2/3/21
|
| CMH Initiative
|
|
|
2/3/21
|
Lopez-Valenciano A, Suarez-Iglesias D, Sanchez-Lastra MA, et al. | Front Psychol
Aim: To analyze the impact that the COVID-19 lockdown had on the amount of physical activity performed by university students.
|
|
|
2/3/21
|
Pourmalek F, Hemami MR, Janani L, et al. | BMC Public Health
Aim: To inform the researchers about the methodology and results of epidemic estimation studies performed for COVID-19 epidemic in Iran, we aimed to perform a rapid review. UPDATED
|
|
|
1/29/21
|
Yu YJ, Park YS, Keller A, et al. | Int J Environ Res Public Health
Aim: To synthesize existing findings (both qualitative and quantitative) that focus on the social and cultural impacts of coronaviruses in order to gain a better understanding of the COVID-19 pandemic.
|
|
|
1/29/21
|
Raynaud M, Zhang H, Louis K, et al. | BMC Med Res Methodol
Aim: To review and categorize COVID-19-related medical research and to critically appraise peer-reviewed original articles.
|
|
|
1/29/21
|
Vargo D, Zhu L, Benwell B, et al. | Human Behaviour and Emerging Technologies
Aim: To synthesize the rapidly growing literature on digital technology use during the current COVID?19 pandemic. To address the following four topics: (1) the specific digital technologies that have been used, (2) the specific populations who have used these digital technologies, (3) the specific activities that individuals and groups have used these digital technologies, and (4) the specific effects of using these digital technologies on humans during the pandemic.
|
|
|
1/29/21
|
Lim MA, Mulyadi Ridia KG, Pranata R | J Clin Orthop Trauma
Aim: To evaluate the 30-day mortality, number and site of fracture, mechanism of injury, and location where injury was sustained during the pandemic compared to pre-pandemic.
|
|
|
1/27/21
|
Illahi U, Mir MS | Environ Dev Sustain
Aim: To identify and enhance the understanding of the logistical characteristics that play a vital role during pandemics.
|
|
|
1/25/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the efficacy, safety and rollout of COVID-19 vaccines.
|
|
|
1/22/21
|
Parry M, Bjornnes AK, Nickerson N, et al. | IRSC CIHR
Aim: To determine what is known about the mental health and wellbeing of family caregivers during communicable disease outbreaks.
|
|
|
1/22/21
|
Sim M, Embrett M | SPOR Evidence Alliance
Aim: To summarize the evidence on the use of rapid POC testing (e.g., antigen, rapid POC PCR) in non-traditional testing environments (i.e., borders, schools, primary care centres).
|
|
|
1/21/21
|
Baradaran A, Malek A, Moazzen N, et al. | Iran J Allergy Asthma Immunol
Aim: To describe clinical manifestation and outcomes of MIS-C associated with COVID-19.
|
|
|
1/21/21
|
Ho JSY, Fernando DI, Chan MY, et al. | Ann Acad Med Singap
Aim: To investigate the relationship between COVID-19 and obesity.
|
|
|
1/21/21
|
Zare ME, Wang Y, Kansestani AN, et al. | Iran J Allergy Asthma Immunol
Aim: To determine the accuracies of white blood cell counts and inflammatory biomarkers for prognosis of COVID-19 patient's outcome by a DTA meta-analysis.
|
|
|
1/20/21
|
Zolopa C, Hoj S, Bruneau J, et al. | Int J Drug Policy
Aim: To review the impacts of Big Events with relevance to the COVID-19 pandemic on drug-related risk and harms and access to drug treatment and harm reduction services.
|
|
|
1/19/21
|
Kheirabadi D, Haddad F, Mousavi-Roknabadi RS, et al. | J Med Virol
Aim: To clarify which systematic reviews on COVID?19 treatment are based on high?value evidence.
|
|
|
1/19/21
|
von Philipsborn P, Biallas R, Burns J, et al. | BMJ Open
Aim: To assess the effects of prior and current use of NSAIDs in patients with acute viral respiratory infections on acute severe adverse events , on acute healthcare utilization, as well as on quality of life and long-term survival. WHO COLLABORATIVE
|
|
|
1/19/21
|
Duz ME, Balci A, Menekse E | Tuberk Toraks
Aim: To review the evidence on D-dimer levels and mordidity and mortality in COVID-19 patients.
|
|
|
1/19/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the infectivity, virulence, and effectiveness of the current vaccines against the new SARS-CoV-2 variants.
|
|
|
1/16/21
|
Lin Y, Chen C, Wu S | J Med Internet Res
Aim: To review the efficiency and quality of data collection in the existing literature.
|
|
|
1/15/21
|
Goldstein KM, Ghadimi K, Mystakelis H, et al. | VA Evidence Synthesis Program
Aim: To review the evidence on the risk of transmitting SARS-CoV-2, SARS, MERS, and influenza with administration of drugs via nebulizer UPDATED VA ESP
|
|
|
1/14/21
|
???? P, ?????? H, ???????????? A, et al. | Russian Journal of Infection and Immunity
Aim: To determine the COVID-19 epidemiology, clinical features, diagnosis and treatment.
|
|
|
1/13/21
|
Lee DS, Mirmirani P, McCleskey PE, et al. | Dermatol Online J
Aim: To identify case reports and case series characterizing cutaneous manifestations of confirmed COVID-19.
|
|
|
1/9/21
|
Wittenberg E, Goldsmith JV, Chen C, et al. | Patient Educ Couns
Aim: To determine the content of provider communication resources and peer-reviewed articles on COVID-19 communication in order to identify opportunities for developing future COVID-19 communication curricula and support tools.
|
|
|
1/8/21
|
Abubakar AR, Sani IH, Godman B, et al. | Infect Drug Resist
Aim: To summarize some evidence-based therapeutic options for COVID-19 infection.
|
|
|
1/5/21
|
Mishra P, Tomar A, Kumar A, et al. | Saudi Journal of Anaesthesia
Aim: To review the evidence on effective pain management in pediatric patients suffering from SARS-CoV-2 virus symptoms.
|
|
|
1/4/21
|
Rahimi NR, Fouladi-Fard R, Aali R, et al. | Environ Res
Aim: To highlight how the virus is impacted by the environment and how the virus has impacted the environment.
|
|
|
1/4/21
|
Cascino F, Hoxhaj I, Zace D, et al. | BMJ Glob Health
Aim: To identify healthcare systems interventions, experiences and recommendations that have been used to manage different respiratory viral infections outbreaks in the past. UPDATED
|
|
|
1/4/21
|
Lee KH, Kim SJ, Hong SH, et al. | Eur Rev Med Pharmacol Sci
Aim: To analyze the same clinical issues through an improved research method and to find out the differences from the retracted papers.
|
|
|
1/4/21
|
Dillman A, Zoratti MJ, Park JJH, et al. | Infect Drug Resist
Aim: To summarize and characterize research efforts with respect to the different stages of disease progression.
|
|
|
1/1/21
|
Dwipayana, I. D. A. P., Sutarini, I. D. A. A. D. | Jurnal Berkala Epidemiologi
Aim: To discuss the available options that can be taken to vaccinate immunosuppressed cancer patients when no vaccine is being developed for their safety.
|
|
|
12/30/20
|
Verdugo-Paiva F, Acuna MP, Sola I, et al. | Medwave
Aim: To provide a timely, rigorous and continuously updated summary of the evidence available on the role of remdesivir in the treatment of patients with COVID-19.
|
|
|
12/23/20
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the use of ivermectin for prophylaxis or treatment of COVID-19.
|
|
|
12/23/20
|
Kubota T, Gajera PK, Kuroda N | Epilepsy Behav
Aim: To perform a systematic review and meta-analysis to summarize and quantitatively evaluate the electroencephalogram (EEG) findings in patients with coronavirus disease 2019 (COVID-19).
|
|
|
12/22/20
|
Fiest KM, Krewulak KD, Plotnikoff KM, et al. | BMC Med
Aim: To evaluate the validity of published triage protocols and the mortality prediction embedded within them to help inform health system-decision-making.
|
|
|
12/22/20
|
Clark M, Loshak H, Farrah K | CADTH
Aim: To review the evidence on the use of COVID-19 mRNA vaccines on patients with cancer or who are immunocompromised.
|
|
|
12/22/20
|
Raymond C, Loshak H | CADTH
Aim: To describe the trial characteristics and estimated primary completion dates of the ongoing phase II, phase III, and phase IV studies evaluating IVIg and hyperimmune globulin to treat COVID-19. UPDATED
|
|
|
12/22/20
|
West E, Moore K, Kupeli N, et al. | Age Aging
Aim: To explore key factors that influence place of care and place of death decisions in older adults.
|
|
|
12/18/20
|
| National Collaborating Centre for Methods and Tools
Aim: To review the evidence on the impact of COVID-19 and related public health measures on household food security. UPDATED
|
|
|
12/16/20
|
Cowling T, Graves E, Loshak H | CADTH
Aim: To explore what we know about virus-neutralizing monoclonal antibodies, their mechanism of action and how they are administered, and which virus-neutralizing monoclonal antibodies are in clinical development for SARS-CoV-2 infection.
|
|
|
12/14/20
|
Gallagher JE, Sukriti KC, Johnson IG, et al. | BDJ Open
Aim: To review the evidence on the pattern of aerosol spread and settle relevant to oral surgery in dental surgery. UPDATED
|
|
|
12/11/20
|
| National Collaborating Centre for Methods and Tools
Aim: To review the evidence on risk factors are associated with COVID-19 outbreaks and mortality in LTC facilities and what strategies mitigate risk. UPDATED
|
|
|
12/11/20
|
| National Collaborating Centre for Methods and Tools
Aim: To review the evidence on how and by whom COVID-19 is introduced and transmitted within acute care settings.
|
|
|
12/10/20
|
| NSW Health COVID-19 Critical Intelligence Unit
|
|
|
12/10/20
|
Levin AT, Hanage WP, Owusu-Boaitey N, et al. | Eur J Epidemiol
Aim: To assess the age specificity of the infection fatality rate (IFR) for COVID-19 using seroprevalence results from eight national studies (Belgium, England, Hungary, Italy, Netherlands, Portugal, Spain, and Sweden), fifteen seroprevalence studies of specific locations in Europe and the United States, and three countries (Iceland, New Zealand, and Republic of Korea) that have engaged in comprehensive tracking and tracing of COVID-19 infections. UPDATED
|
|
|
12/10/20
|
Liu N, Sun J, Wang X, et al. | J Alzheimers Dis
Aim: To investigate the impact of pre-existing dementia comorbidities on COVID-19.
|
|
|
12/9/20
|
Kondylakis H, Katehakis DG, Kouroubali A, et al. | J Med Internet Res
Aim: To shed light into studies found in the scientific literature that have used and evaluated mobile apps for the prevention, management, treatment, or follow-up of COVID-19.
|
|
|
12/9/20
|
| NSW Health COVID-19 Critical Intelligence Unit
|
|
|
12/9/20
|
El Keshky MES, Basyouni SS, Al Sabban AM | Front Psychol
Aim: To evaluate the impact of COVID-19 on the psychology of sustainability (quality of life), on sustainable development, and on the global economy.
|
|
|
12/9/20
|
Vancsa S, Hegyi PJ, Zadori N, et al. | Front Med
Aim: To evaluate the prognostic value of on-admission liver function tests and pre-existing liver diseases on the clinical course of coronavirus disease 2019 (COVID-19). UPDATED
|
|
|
12/9/20
|
Putko RM, Bedrin MD, Clark DM, et al. | J Clin Orthop Trauma
Aim: To identify risk factors, comorbidities, case characteristics, and treatment strategies to better understand the nature of this disease and its effects on the extremities.
|
|
|
12/9/20
|
Prakash A, Singh H, Kaur H, et al. | Indian J Psychiatry
Aim: To evaluate the efficacy and safety of FPV in published literature.
|
|
|
12/9/20
|
Shamshirian A, Hessami A, Heydari K, et al. | Ann Acad Med Singap
Aim: To examine the effectiveness of hydroxychloroquine in treatment of COVID-19. UPDATED
|
|
|
12/9/20
|
Fligor SC, Tsikis ST, Wang S, et al. | J Thorac Dis
Aim: To synthesize the available literature on time to surgery and its impact on outcomes along with a critical appraisal of the released triage guidelines in the United States.
|
|
|
12/8/20
|
Wilkinson R, Hines L, Holland A, et al. | Harm Reduct J
Aim: To explore what harm reduction interventions and messaging are most effective during a pandemic-type situation. UPDATED
|
|
|
12/7/20
|
Puyat J, Ahmad H, Avina-Galindo AM, et al | PLoS One
Aim: To review the evidence on home-based activities that have potential beneficial effects on mental health. UPDATED
|
|
|
12/7/20
|
Hessami A, Shamshirian A, Heydari K, et al. | Am J Emerg Med
Aim: To study cardiovascular disease burden among COVID-19 patients. UPDATED
|
|
|
12/7/20
|
Rodriguez-Gonzalez M, Castellano-Martinez-A, Cascales-Poyatos HM, et al. | World J Clin Cases
Aim: To summarize the current knowledge about the potential cardiovascular involvement in pediatric COVID-19 in order to give a perspective on how to take care of them during the current pandemic emergency.
|
|
|
12/7/20
|
Kim JS, Lee KH, Kim GE, et al. | Eur Rev Med Pharmacol Sci
Aim: To analyze clinical characteristics and mortality of patients with hematologic malignancies and COVID-19.
|
|
|
12/7/20
|
Vakhshoori M, Emami SA, Heidarpour M, et al. | Iran J Kidney Dis
Aim: To define the frequency of AKI as well as two specific renal biomarkers including BUN and serum Cr among individuals suffering from COVID-19 infection.
|
|
|
12/7/20
|
Hu BS, Hu MZ, Jiang LX, et al. | Eur Rev Med Pharmacol Sci
Aim: To review the evidence on the use of ECMO in patients with COVID-19.
|
|
|
12/7/20
|
Ampuero J, Sanchez-Torrijos Y, Del Rosario Garcia Lozano M, et al. | Rev Esp Enferm Dig
Aim: To assess the impact of the baseline liver function (AST, ALT, and bilirubin) on COVID-19-related outcomes, including on mortality, intensive care unit admission, and non-fatal severe complications.
|
|
|
12/7/20
|
Bandyopadhyay S, Baticulon RE, Kadhum M, et al. | BMJ Glob Health
Aim: To estimate COVID-19 infections and deaths in healthcare workers (HCWs) from a global perspective during the early phases of the pandemic.
|
|
|
12/7/20
|
Berardicurti O, Ruscitti P, Ursini F, et al. | Clin Exp Rheumatol
Aim: To review the evidence on the mortality rate in TCZ-treated patients with COVID-19.
|
|
|
12/7/20
|
Chu Y, Yang J, Shi J, et al. | Eur J Med Res
Aim: To investigate the association between obesity and poor outcomes in patients with COVID-19 pneumonia.
|
|
|
12/7/20
|
| NSW Health COVID-19 Critical Intelligence Unit
|
|
|
12/7/20
|
Jefferson T, Spencer EA, Brassey J, et al. | Clin Infect Dis
Aim: To review the evidence from studies relating SARS-CoV-2 culture with the results of reverse transcriptase polymerase chain reaction (RT-PCR) and other variables which may influence the interpretation of the test, such as time from symptom onset. UPDATED
|
|
|
12/4/20
|
Shuto H, Komiya K, Yamasue M, et al. | Sci Rep
Aim: To review the evidence on the associations between corticosteroid treatment and any type of mortality and/or other clinical outcomes among noncritically ill patients with COVID-19.
|
|
|
12/4/20
|
Zarifkar P, Kamath A, Robinson C, et al. | Clin Oncol
Aim: To review the current evidence base pertaining to the prevalence, presentation and outcome of COVID-19 in cancer patients, in order to inform policy and practice going forwards. UPDATED
|
|
|
12/4/20
|
Mohamed K, Yazdanpanah N, Saghazadeh A, et al. | Bioorg Chem
Aim: To provide an overview of studies that have used computational methods for drug repurposing in COVID-19.
|
|
|
12/4/20
|
da Silva FAF, de Brito BB, Santos MLC, et al. | Rev Soc Bras Med Trop
Aim: To review the evidence on GI symptoms associated with coronavirus disease 2019 (COVID-19) as well as of the serum levels of biomarkers related to liver function and lesion in SARS-CoV-2-infected individuals.
|
|
|
12/4/20
|
Alhumaid S, Al Mutair A, Al Alawi Z, et al. | Trop Med Infect Dis
Aim: To assess the efficacy and safety of lopinavir/ritonavir in COVID-19 patients in the extant published research. UPDATED
|
|
|
12/4/20
|
Pollock A, Campbell P, Cheyne J, et al. | Cochrane Database Syst Rev
Aim: To review the evidence on the effects of interventions aimed at supporting the resilience and mental health of frontline health and social care professionals during and after a disease outbreak, epidemic or pandemic.
|
|
|
12/4/20
|
Komolafe TE, Agbo J, Olaniyi EO, et al. | Diagnostics
Aim: To perform a meta-analysis to evaluate the diagnostic performance of chest CT, common CT morphological abnormalities, disease prevalence, biodata information, and gender prevalence of patients. UPDATED
|
|
|
12/4/20
|
Zuercher SJ, Kerksieck P, Adamus C, et al. | Front Public Health
Aim: To review the evidence on MHP prevalence rates published since 2000, during and after epidemics, including the general public, health care workers, and survivors. UPDATED
|
|
|
12/4/20
|
National Collaborating Centre for Methods and Tools | National Collaborating Centre for Methods and Tools
Aim: To review the evidence on the effect of the COVID-19 pandemic on the use and cessation of tobacco and vaping products.
|
|
|
12/4/20
|
Lieneck C, Garvey J, Collins C, et al. | Healthcare
Aim: To evaluate the literature specific to rapid telehealth implementation during the current COVID-19 pandemic.
|
|
|
12/4/20
|
Lo Moro G, Sinigaglia T, Bert F, et al. | Int J Environ Res Public Health
Aim: To describe the main measures planned for the 2020–2021 academic year within the WHO European Region.
|
|
|
12/4/20
|
Torres-Castro R, Vasconcello-Castillo L, Alsina-Restoy X, et al. | Pulmonology
Aim: To determine the prevalence of restrictive pattern, obstructive pattern and altered diffusion in patients post-COVID-19 infection and to describe the different evaluations of respiratory function used with these patients. UPDATED
|
|
|
12/4/20
|
Yifan C, Jun P | Front Endocrinol
Aim: To assess the clinical characteristics of elder patients with COVID-19.
|
|
|
12/4/20
|
Foldi M, Farkas N, Kiss S, et al. | Obesity
Aim: To evaluate the association between the distributions of CT?quantified fat mass and critical condition of patients with COVID?19.
|
|
|
12/3/20
|
Oakman J, Kinsman N, Stuckey R, et al. | BMC Public Health
Aim: To review the impact of WAH on individual workers’ mental and physical health, and determine any gender difference, to develop recommendations for employers and employees to optimise workers’ health.
|
|
|
12/3/20
|
Jain N, Varman R, Tarbox JA, et al. | Auris Nasus Larynx
Aim: To review the current knowledge of biomolecular factors surrounding otorhinolaryngeal illnesses and analyze their presence in COVID-19 virulence.
|
|
|
12/3/20
|
Szarpak L, Adam I, Dzieciatkowski T, et al. | Postepy Nauk Medycznych
Aim: To identify the most frequently observed symptoms in pediatric patients with confirmed COVID-19.
|
|
|
12/3/20
|
Chi J, Gong W, Gao Q | Arch Gynecol Obstet
Aim: To summarize the clinical features and maternal–infant outcomes of 230 pregnant women (154 patients gave birth) infected with COVID-19 and their 156 infants, including the possibility and evidence of vertical transmission.
|
|
|
12/3/20
|
Zhou S, Xu J, Xue C, et al. | Ren Fail
Aim: To review the evidence on kidney-related outcomes of three recent pandemics: SARS, MERS, and COVID-19, which were associated with potentially fatal acute respiratory distress syndrome (ARDS). UPDATED
|
|
|
12/3/20
|
Cai XJ, Tay JCK, Kui SL, et al. | Singapore Med J
Aim: To study in-hospital mortality in COVID-19 patients who were on ACEI/ARB as compared to those not on ACEI/ARB.
|
|
|
12/3/20
|
do Amaral WN, de Moraes CL, Dos Santos Rodrigues AP, et al. | Healthcare
Aim: To investigate pregnant women infected with COVID-19 in terms of signs and symptoms, type of delivery, comorbidities, maternal and neonatal outcomes, and the possibility of vertical transmission.
|
|
|
12/3/20
|
Aburas W, Alshammari TM | Saudi Pharm J
Aim: To provide an overview of pharmacists’ roles in disasters and formulating a definition of expected roles and tasks through which they can perform these roles properly.
|
|
|
12/3/20
|
Mahdi SS, Ahmed Z, Allana R, et al. | Medicina
Aim: To identify additional infection control measures implemented in dental practice globally to prevent cross-infection and evaluate the psychological impacts of the pandemic among dental professionals.
|
|
|
12/2/20
|
Fraiman P, Godeiro C, Moro E, et al. | Front Neurol
Aim: To review the evidence on the cerebrovascular events in COVID-19 infection.
|
|
|
12/2/20
|
Gunn H, McCormack S | CADTH
|
|
|
12/2/20
|
Zhou L, Wang J, Xie R, et al. | J Altern Complement Med
Aim: To assess the effects of TCM as an auxiliary treatment for COVID-19 through a systematic review of randomized-controlled trials (RCTs). UPDATED
|
|
|
12/2/20
|
Malas MB, Naazie IN, Elsayed N, et al. | EClinicalMedicine
Aim: To estimate the overall rates of TE of COVID-19 and further determine the association of TE with mortality among patients with COVID-19.
|
|
|
12/1/20
|
Schunemann HJ, Khabsa J, Solo K, et al. | Ann Intern Med
Aim: To review multiple streams of evidence regarding the benefits and harms of ventilation techniques for coronavirus infections, including that causing COVID-19. UPDATED
|
|
|
11/30/20
|
Graber K, Byrne E, Goodacre E, et al. | Child Care Health Dev
Aim: To review of the impact of quarantine, isolation, or other restrictive environments on children’s play and whether play may mitigate the adverse effects of such restrictions. UPDATED
|
|
|
11/30/20
|
da Rosa Mesquita R, Silva LCF, Santana FMS, et al. | Wien Klin Wochenschr
Aim: To systematize the literature regarding clinical manifestations of patients with confirmed COVID-19.
|
|
|
11/30/20
|
Wang Z, Deng H, Ou C, et al. | Medicine
Aim: To compare the differences in the field of demographic, comorbidities, clinical symptoms, complications and outcomes between severe and non-severe COVID-19.
|
|
|
11/30/20
|
Raja MA, Mendoza MA, Villavicencio A, et al. | Transplant Rev
Aim: To help expand our current limited knowledge base regarding COVID-19 in SOT recipients, especially looking at clinical presentations, treatment modalities and outcomes.
|
|
|
11/30/20
|
Meher BR, Padhy BM, Das S, et al. | J Assoc Physicians India
Aim: To evaluate the currently available data to provide evidence about CPT in COVD-19 patients.
|
|
|
11/30/20
|
Amiri-Dashatan N, Koushki M, Ghorbani F, et al. | Gastroenterol Hepatol Bed Bench
Aim: To determine whether patients with elevated CRP, TNF?, and IL-6 levels may be at increased risk for severe infection and liver damage of COVID-19.
|
|
|
11/30/20
|
Makvandi S, Ashtari S, Vahedian-Azimi A | Gastroenterol Hepatol Bed Bench
Aim: To evaluate the symptoms of COVID-19 in pregnant women with a focus on gastrointestinal symptoms.
|
|
|
11/30/20
|
Bell V, Wade D | Soc Psychiatr Epidemiol
Aim: To estimate the additional burden of working directly with infected patients during epidemic and pandemic health emergencies. UPDATED
|
|
|
11/30/20
|
Hannum ME, Ramirez VA, Lipson SJ, et al. | Chem Senses
Aim: To provide a comprehensive assessment of methodologies currently employed to quantify smell loss in COVID-19–positive patients and examine whether method type affects reported prevalence of smell loss in COVID-19 patients. UPDATED
|
|
|
11/30/20
|
Mousquer GT, Peres A, Fiegenbaum M | Tuberculosis
Aim: To conduct a systematic review on the current literature on TB/COVID-19 co-infection cohorts, evaluating clinical and epidemiological data, focusing on its implications to the immune system.
|
|
|
11/30/20
|
Bekele F, Sheleme T, Fekadu G, et al. | SAGE Open Med
Aim: To summarize the knowledge, attitudes, and practice of COVID-19 among the general population and health workers across the globe.
|
|
|
11/30/20
|
Afra HS, Amiri-Dashatan N, Ghorbani F, et al. | Gastroenterol Hepatol Bed Bench
Aim: To report a pooled analysis of the association of the circulating levels of liver enzymes and total bilirubin with severe and non-severe COVID-19.
|
|
|
11/30/20
|
Bareeqa SB, Ahmed SI, Samar SS, et al. | Int J Psychiatry Med
Aim: To quantify COVID-19 mental health issues and its prevalence in China during the early period of the COVID-19 crisis. UPDATED
|
|
|
11/30/20
|
Thrinuavukkarasu S, Kapoor N, Tina Cao, et al. | Diabetes Obes Metab
Aim: To examine the proportion of newly diagnosed diabetes in COVID-19 patients.
|
|
|
11/30/20
|
Azam M, Sulistiana R, Ratnawati M, et al. | Sci Rep
Aim: To estimate the incidence of recurrent SARS-CoV-2 RNA positivity after recovery from COVID-19 and to determine the factors associated with recurrent positivity. UPDATED
|
|
|
11/30/20
|
Maraolo AE, Grosi A | Immun Inflamm Dis
Aim: To gauge the safety profile of HCQ/CQ in the context of COVID?19 pandemic on the basis of data from RCTs published so far, to highlight the trade?off between pros and cons of HCQ/CQ repurposing to treat or prevent SARS?CoV?2 infection.
|
|
|
11/30/20
|
Jammu A, Chasen M, Lofters A, et al. | Support Care Cancer
Aim: To synthesise the available knowledge regarding the impact of the COVID-19 pandemic. UPDATED
|
|
|
11/30/20
|
Cardwell K, Jordan K, Byrne P, et al. | Rev Med Virol
Aim: To summarise the evidence on non?contact thermal screening as a method through which to identify cases and reduce the spread of coronavirus disease (Covid?19).
|
|
|
11/30/20
|
Allan SM, Bealey R, Birch J, et al. | Eur J Psychotraumatol
Aim: To estimate the prevalence of common mental health disorders in HCWs based in hospitals where pandemic-affected patients were treated. UPDATED
|
|
|
11/27/20
|
Arruda AG, Beyene TJ, Kieffer J, et al. | Animals
Aim: To summarize the available literature on swine depopulation methods and to highlight critical gaps in knowledge.
|
|
|
11/27/20
|
Griffin J, Casey M, Collins Á, et al. | BMJ Open
Aim: To conduct a review of available evidence to advise on appropriate parameter values for serial interval and generation time in national COVID-19 transmission models for Ireland and on methodological issues relating to those parameters. UPDATED
|
|
|
11/24/20
|
France R, Vseteckova J, Lapwood S, et wood | Oxford COVID-19 Evidence Service
|
|
|
11/23/20
|
| EUnetHTA
Aim: To review the evidence on the use of lopinavir and ritonavir for the treatment for COVID-19.
|
|
|
11/23/20
|
Thombs BD, Bonardi O, Rice DB, et al. | IRSC CIHR
Aim: To review the evidence on the impact of the COVID-19 pandemic on mental health.
|
|
|
11/20/20
|
Rezapour A, Souresafil A, Peighambari MM, et al. | Int J Surg
Aim: To summarize economic evaluation evidence of preventing strategies, programs, and treatments of COVID-19.
|
|
|
11/20/20
|
Camden C, Malboeuf-Hurtubise C, Roberge P, et al. | IRSC CIHR
Aim: To explore the impacts of the context pandemic including sanitary measures and confinement on the mental health of children aged 5 to 12 years.
|
|
|
11/19/20
|
Mair M, Singhavi H, Pai A, et al. | Laryngoscope
Aim: To examine the pooled prevalence of symptoms, laboratory tests, and imaging of all COVID-19 infected patients.
|
|
|
11/19/20
|
Vestrheim DF, Iversen BG, Flottorp S, et al. | Norwegian Institute of Public Health
Aim: To review the evidence on the use of face masks by people in the community to reduce the spread of COVID-19.
|
|
|
11/18/20
|
Clinical course and outcomes of critically ill patients with COVID-19 infection: a systematic review
Serafim RB, Póvoa P, Souza-Dantas V, et al. | Clin Microbiol Infect
Aim: To describe the clinical course and outcomes of COVID-19 pneumonia in critically ill patients. UPDATED
|
|
|
11/18/20
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence for transmission of COVID-19 in different settings, and to determine which settings are high risk.
|
|
|
11/18/20
|
Spencer N, Nathawad R, Arpin E, et al. | BMJ Paediatr Open
Aim: To review the evidence on the impact of pandemics on existing inequities in routine vaccination coverage.
|
|
|
11/16/20
|
Yoon YK, Lee J, Kim SI, et al | J Korean Med Sci
Aim: To derive suggestions for short-, mid-, and long-term strategies for medical resource management beyond the COVID-19 pandemic.
|
|
|
11/16/20
|
Pant S, Perras C | CADTH
Aim: To describe the trial characteristics and estimated primary completion dates of the ongoing phase II, phase III, and phase IV studies evaluating drugs to prevent or treat COVID-19. UPDATED
|
|
|
11/12/20
|
Wang K, Wu C, Xu J, et al. | EClinicalMedicine
Aim: To describe the clinical outcomes of operative patients with COVID-19, and the safety of medical staff during the perioperative period to take appropriate protective measures to avoid cross-infection.
|
|
|
11/12/20
|
Fredericks S, Miranda J, Sidani S, et al. | Brain Behav Immun Health
Aim: To inform evidence-based decision-making pertaining to the selection of effective strategies or therapies that this cohort could use to promote mental health and resilience both within the clinical practice and academic environment.
|
|
|
11/12/20
|
Hong TS, Gonzalez J, Nahass RG, et al. | Pharmacy
Aim: To evaluate the impact of HCQ exposure on mortality in hospitalized patients with COVID-19.
|
|
|
11/11/20
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on monitoring wastewater as a surveillance strategy for COVID-19.
|
|
|
11/9/20
|
Kiss P, Carcel C, Hockham C, et al. | Eur Heart J Qual Care Clin Outcomes
Aim: To assess the extent to which health services related to the care and management of acute cardiovascular events have been impacted during the COVID-19 pandemic.
|
|
|
11/6/20
|
Santos M, Torres D, Cardoso PC, et al. | Braz Oral Res
Aim: To investigate the efficiency of cloth masks in reducing transmission and contamination by droplets and aerosols for the general population and healthcare workers.
|
|
|
11/6/20
|
Mallett S, Allen J, Graziadio S, et al. | BMC Med
Aim: To examine at what time points during SARS?CoV?2 infection it is detectable at different anatomical sites using RT?PCR based tests. UPDATED
|
|
|
11/6/20
|
Yadav R, Srivastava DK, Bajpai PK, et al. | J Neurosci Rural Pract
Aim: To determine the neurological involvement and its manifestations in COVID-19 patients.
|
|
|
11/6/20
|
Pereira M, Damascena AD, Azevedo LMG, et al. | Crit Rev Food Sci Nutr
Aim: To analyze the association between vitamin D deficiency and COVID-19 severity, via an analysis of the prevalence of vitamin D deficiency and insufficiency in people with the disease.
|
|
|
11/5/20
|
Mirza FN, Malik AA, Omer SB, et al. | Int J Dermatol
Aim: To collate the available information on the dermatologic manifestations in COVID?19 patients to inform current practice and further research. UPDATED
|
|
|
11/5/20
|
Cheruiyot I, Sehmi P, Ominde B, et al | Neurol Sci
Aim: To identify and consolidate evidence of ICH in COVID-19 patients.
|
|
|
11/5/20
|
Alamoodi AH, Zaidan BB, Zaidan AA, et al. | Expert Syst Appl
Aim: To review and analyse articles about the occurrence of different types of infectious diseases, such as epidemics, pandemics, viruses or outbreaks, during the last 10 years, understand the application of sentiment analysis and obtain the most important literature findings.
|
|
|
11/4/20
|
Park R, Lee S, Kim SY, et al | Acta Oncol
Aim: To summarize the existing evidence for the effect of active oncologic treatment on COVID-19 outcomes. UPDATED
|
|
|
11/4/20
|
Zhang H, Han H, He T, et al. | J Natl Cancer Inst
Aim: To review the evidence on the reported fatalities in COVID-19 patients with cancer.
|
|
|
11/4/20
|
Cao K, Kline B, Han Y, et al. | Biomed Res Int
Aim: To estimate the prevalence rate of ocular symptoms and the positive rate of conjunctival swab samples of patients diagnosed with 2019 Novel Coronavirus Disease (COVID-19).
|
|
|
11/4/20
|
| NSW Health COVID-19 Critical Intelligence Unit
|
|
|
11/4/20
|
Hoang T | J Med Virol
Aim: To summarize the current evidence of factors associated with the risk of disease recurrence.
|
|
|
11/4/20
|
Khateri S, Mohammadi H, Khateri R, et al. | Arch Acad Emerg Med
Aim: To determine the prevalence of underlying diseases and associated comorbidities in COVID-19 patients using a systematic review and meta-analysis.
|
|
|
11/4/20
|
The Prognostic Value of Thrombocytopenia in COVID-19 Patients; a Systematic Review and Meta-Analysis
Bashash D, Hosseini-Baharanchi FS, Rezaie-Tavirani M, et al. | Arch Acad Emerg Med
Aim: To provide a well-conceptualized viewpoint demonstrating the prognostic value of thrombocytopenia in COVID-19.
|
|
|
11/2/20
|
Boregowda U, Perisetti A, Nanjappa A, et al. | Front Med
Aim: To compare the efficacy of tocilizumab in severe COVID-19 cases vs. standard of care alone. UPDATED
|
|
|
11/2/20
|
Dawoud DM, Soliman KY | Value Health
Aim: To review published economic evaluations of antiviral treatment for pandemics and outbreaks of respiratory illnesses.
|
|
|
11/2/20
|
Saad MA, Alfishawy M, Nassar M, et al. | Curr Rheumatol Rev
Aim: To review the evidence on reported COVID-19 cases with asociated autoimmune manifestations.
|
|
|
11/2/20
|
Palaiodimos L, Chamorro-Pareja N, Karamanis D, et al. | Hormones
Aim: To systematically review and synthesize with a meta-analysis the available observational studies reporting the effect of diabetes in mortality among hospitalized patients with COVID-19. UPDATED
|
|
|
11/2/20
|
Elsawah H, Elsokary M, Abdallah MS, et al. | Rev Med Virol
Aim: To systematically review the use of remdesivir in Covid?19 among the available clinical trials and summarise remdesivir efficacy. UPDATED
|
|
|
11/2/20
|
Hariyanto TI, Kristine E, Jillian C, et al. | Infect Disord Drug Targets
Aim: To review the evidence on the use of lopinavir/ritonavir as a potential treatment candidate against COVID-19.
|
|
|
11/2/20
|
Megnin-Viggars O, Carter P, Melendez-Torres GJ, et al. | PLoS One
Aim: To identify facilitators and barriers to uptake of, and engagement with, contact tracing during infectious disease outbreaks.
|
|
|
11/2/20
|
Prasitlumkum N, Chokesuwattanaskul R, Thongprayoon C, et al. | Diseases
Aim: To explore the incidence of acute myocardial injury among COVID-19 patients.
|
|
|
11/2/20
|
Cagnazzo F, Arquizan C, Derraz I, et al. | J Neurol
Aim: To perform an updated review of the literature on the neurological manifestations of COVID-19-infected patients
|
|
|
11/2/20
|
Trypsteen W, Van Cleemput J, Van Snippenberg W, et al. | PLoS One
Aim: To review the current (pre)published SARS-CoV-2 literature with a focus on the evidence concerning SARS-CoV-2 distribution in human tissues and viral shedding in body fluids.
|
|
|
11/2/20
|
Shrestha DB, Budhathoki P, Syed N, et al. | Life Sci
Aim: To conduct a systematic review and meta-analysis on remdesivir use for COVID-19.
|
|
|
11/2/20
|
Ciaffi J, Meliconi R, Ruscitti P, et al. | BMC Rheumatol
Aim: To assess the prevalence of rheumatic manifestations in patients affected by COVID-19, as initial symptom or during disease course.
|
|
|
11/2/20
|
Lee KW, Khan AHKY, Ching SW, et al. | Front Neurol
Aim: To perform a systematic review and meta-analysis of currently available epidemiological, clinical, and laboratory data related to both stroke and COVID-19 infection.
|
|
|
11/2/20
|
Violante T, Violante FS | Med Lav
Aim: To summarize the available studies which have compared the respective effectiveness of surgical masks and filtering facepiece respirators for the prevention of infections caused by viruses that are transmitted by the respiratory tract.
|
|
|
11/2/20
|
Antony AR, Haneef Z | Seizure
Aim: To synthesize the data on EEG findings in COVID-19.
|
|
|
11/2/20
|
Kolcun JPG, Ryu WHA, Traynelis VC | J Neurosrug Spine
Aim: To examine the current utilization of TM for spine surgery.
|
|
|
11/2/20
|
Del Riccio M, Lorini C, Bonaccorsi G, et al. | Int J Environ Res Public Health
Aim: To review the association between seasonal influenza vaccination and the risk of SARS-CoV-2 infection or complicated illness or poor outcome (e.g. severe disease, need for hospitalization or ventilatory support, or death) among COVID-19 patients. UPDATED
|
|
|
11/2/20
|
Chen J, Wu C, Wang X, et al. | Front Endocrinol
Aim: To summarize available data on the association between glycemic parameters and severity of COVID-19.
|
|
|
11/1/20
|
Khanlou N, Ssawe A, Vazquez LM, et al. | CMH Initiative
Aim: To review the evidence on the racialized and gendered social determinants of mental health among women and girls exposed to gender-based violence during the COVID-19 pandemic.
|
|
|
11/1/20
|
Larney S, Bruneau J, Raynault MF, et al | CMH Initiative
Aim: To assess the impacts of "Big Events" like the COVID-19 pandemic on risk behaviors and drug-related harms among people who use drugs and the delivery of harm reducation and drug treatment services.
|
|
|
10/29/20
|
Patel U, Malik P, Mehta D, et al. | J Glob Health
Aim: To evaluate epidemiological characteristics, needs of resources, outcomes, and global burden of the disease.
|
|
|
10/29/20
|
Kumar R, Nedungalaparambil NM, Mohanan N | J Family Med Prim Care
Aim: To review the evidence on emergency and primary care collaborations during the COVID-19 pandemic.
|
|
|
10/29/20
|
PHAC Emerging Science Group | Public Health Agency of Canada
Aim: To review the evidence on whether hosptialized SARS-CoV-2 patients that successfully recover with no subsequently positive RT-PCR tests present with SARS-CoV-2 antibody levels or seropositivity rates differ from those that do retest positive?
|
|
|
10/29/20
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the effectiveness of fit testing and fit checking for testing the protection of a respirator.
|
|
|
10/28/20
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the contributing factors of a second spike in COVID-19 cases.
|
|
|
10/26/20
|
Mirzaie H, Vahidi M, Shokoohi M, et al. | medRxiv
Aim: To summarize the evidence on COVID-19 patients with HBV or HCV co-infections.
|
|
|
10/22/20
|
Perras C, Pohar S, Manoharan A, et al. | CADTH
Aim: To review the current scientific evidence on the potential benefits and harms of remdesivir. UPDATED
|
|
|
10/21/20
|
Nguyen VT, Riviere P, Ripoll P, et al. | J Clin Epidemiol
Aim: To describe the planning of randomized controlled trials (RCTs) in terms of timing related to the course of the COVID-19 epidemic and research question evaluated.
|
|
|
10/19/20
|
| CADTH
Aim: To review the various strategies being used to increase the availability of N95 masks.
|
|
|
10/19/20
|
Pluddemann A, Aronson JK | Oxford COVID-19 Evidence Service
Aim: To review the evidence on the role of T cells and antibodies in immunity to COVID-19 infection.
|
|
|
10/16/20
|
| National Collaborating Centre for Methods and Tools
Aim: To review the evidence on factors that may help protect Indigenous peoples and communities in Canada and internationally from the COVID-19 pandemic and its impacts.
|
|
|
10/15/20
|
| NSW Health COVID-19 Critical Intelligence Unit
|
|
|
10/8/20
|
Gianola S, Jesus TS, Bargeri S, et al. | PLoS One
Aim: To take a snapshot of the amount of scientific development devoted to COVID-19 and gain an idea of the current status of global research.
|
|
|
10/8/20
|
Ehaideb SN, Abdullah ML, Abuyssin B, et al. | Crit Care
Aim: To assess whether the newly created models reproduce the full spectrum of human COVID-19.
|
|
|
10/7/20
|
| NSW Health COVID-19 Critical Intelligence Unit
|
|
|
10/7/20
|
| NSW Health COVID-19 Critical Intelligence Unit
|
|
|
10/6/20
|
Sharma SK, Mishra M, Mudgal SK | J Educ Health Promot
Aim: To update the available most recent evidences on efficacy of cloth face masks in prevention of viral infection transmission.
|
|
|
10/6/20
|
Jena A, Singh AK, Kumar-M P, et al. | Dig Liver Dis
Aim: To identify the frequency and reasons for the disruption of care for IBD patients and attempted to identify regional differences in patterns of adherence to IBD therapies.
|
|
|
10/2/20
|
Yang S, Li A, Eshaghpour A, et al. | BMJ Evid Based Med
Aim: To review the trends and quality of evidence in early SARS-CoV-2 publications.
|
|
|
9/30/20
|
Cascini F, Hoxhaj I, Zace D, et al. | Eur J Public Health
Aim: To review the evidence on healthcare system approaches, experiences and recommendations used to manage COVID-19 and other epidemics.
|
|
|
9/29/20
|
Oliveira LV, Silva C, Lopes LP, et al. | Rev Assoc Med Bras
Aim: To review the current scientific evidence of vertical transmission related to coronavirus disease 2019 (COVID-19).
|
|
|
9/29/20
|
Bhattacharjee S, Banerjee M | SN Compr Clin Med
Aim: To analyze the clinical profile and outcomes in a total of 45 cases of new-onset ITP in COVID-19 patients described in literature until date.
|
|
|
9/29/20
|
Abuelgasim E, Dona ACM, Sondh RS, et al. | Dermatol Ther
Aim: To review the current literature on urticaria in COVID-19 patients and to provide insight into urticarial pathogenesis and management in such patients.
|
|
|
9/28/20
|
Sheleme T, Bekele F, Ayela T | Infect Dis
Aim: To summarize clinical presentations of this newly emerging coronavirus disease.
|
|
|
9/28/20
|
| Public Health Agency of Canada
Aim: Not provided
|
|
|
9/28/20
|
| National Collaborating Centre for Methods and Tools
Aim: To review the evidence on the potential for COVID-19 re-infection, including new transmission after recovery.
|
|
|
9/28/20
|
de Assis GG, Murawksa-Cialowicz E, Cieszczyk P, et wl. | Front Neurol
Aim: To review the evidence on the implications and mechanisms of infections by respiratory CoVs.
|
|
|
9/25/20
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence that CPR is aerosol generating and current advice for CPR in patients with suspected or confirmed COVID-19.
|
|
|
9/24/20
|
Berling I, King JD, Shepherd G, et al. | J Am Soc Nephrol
Aim: To determine the effect of and indications for extracorporeal treatments in cases of poisoning with chloroquine, hydroxychloroquine, and quinine.
|
|
|
9/23/20
|
Navarro P | Newfoundland and Laborador Centre for Applied Health Research
Aim: To review the evidence on the medium-term and long-term health impacts of COVID-19 on infection survivors.
|
|
|
9/22/20
|
Shield KD, Wells S, Rehm J, et al. | CMH Initiative
Aim: To review the evidence on alcohol consumption during periods of crisis and how the evidence can be applied to alcohol policy recommendations.
|
|
|
9/22/20
|
van Boekel L, Stoop A, Luijkx KG | Tijdschr Gerontol Geriatr
Aim: To understand what we can learn from previous crises or disasters worldwide to optimize the care for older adults in long term care facilities during the outbreak of COVID-19.
|
|
|
9/22/20
|
| CADTH
Aim: To review evidence related to airflow transmission of SARS-CoV-2 and the risk associated with the use of heating, ventilation, and air conditioning (HVAC) systems.
|
|
|
9/21/20
|
Singh S, Fong HK, Mercedes BR, et al. | Resuscitation
Aim: To review the evidence on the change in out-of-hospital cardiac arrest indicence and mortality during the COVID-19 outbreak in various countries.
|
|
|
9/21/20
|
| National Collaborating Centre for Methods and Tools
Aim: To review the evidence on the effect of the COVID-19 pandemic on opioid and substance use and related harms.
|
|
|
9/18/20
|
Bornstein S | Newfoundland and Laborador Centre for Applied Health Research
Aim: To review the evidence on the effectiveness of reducing prison populations to reduce the spread of COVID-19.
|
|
|
9/18/20
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on whether domestic animals can become infected with and transmit COVID-19.
|
|
|
9/18/20
|
Lagzian M, Dadkhah M, Mehraeen A | Eur J Clin Invest
Aim: To recognize the challenges policymakers have typically experienced during pandemic diseases, including Covid-19, and, accordingly, new information technology capabilities to encounter with them.
|
|
|
9/17/20
|
McLane P | Alberta Health Services
Aim: To review the evidence on the factors impacting attitudes toward or adherence to COVID-19 public health guidelines and interventions to create more positive attitudes towards following guidelines.
|
|
|
9/15/20
|
Cheruiyot I, Henry B, Lippi G, et al. | Acta Biomed
Aim: To assess whether AKI may be associated with worse prognosis and increased mortality in COVID-19 patients UPDATED
|
|
|
9/15/20
|
| EUnetHTA
Aim: To review the evidence on the use of dexamethasone for the treatment for COVID-19.
|
|
|
9/15/20
|
| Health Information and Quality Authority, Ireland
Aim: To review the evidence on the duration of infectiousness in those that test positive for SARS-CoV-2 RNA.
|
|
|
9/15/20
|
| Quebec National Institute of Public Health
Aim: To review the evidence on risk factors for severe infections and potential for transmission in children.
|
|
|
9/15/20
|
Sharpe H | Alberta Health Services
Aim: To review the evidence on different methods, completion rates, and costs for self-collected samples for SARS-CoV-2 RT-PCR.
|
|
|
9/14/20
|
Klein MG, Cheng CJ, Lii E, et al. | Disaster Med Public Health Prep
Aim: To highlight models that project both caseload and hospital capacity requirements over time.
|
|
|
9/14/20
|
Fernandez R, Lord H, Halcomb E, et al. | Int J Nurs Stud
Aim: To synthesize and present the best available evidence on the experiences of nurses working in acute hospital settings during a pandemic.
|
|
|
9/12/20
|
Lauvrak V, Juvet LK | Norwegian Institute of Public Health
Aim: To investigate if there are studies supporting the use of salivary samples for detection of SARS-CoV-2, and if there are studies that can be used to calculate the diagnostic accuracy of salivary testing compared to nasopharyngeal or oropharyngeal swab samples.
|
|
|
9/11/20
|
Lenferink LIM, Meyerbroker K, Boelen PA | Psychiatry Res
Aim: To review the evidence on online Eye Movement Desensitization and Reprocessing (EMDR) treatment for PTSD.
|
|
|
9/11/20
|
Abdoul-Azize HT, El Gamil R | Glob Soc Welf
Aim: To explore the current implementation of social protection programs during the COVID-19 pandemic in the most affected countries as well as to provide learned lessons from countries that had not previously considered implementing social protection programs up until the COVID-19 crisis.
|
|
|
9/11/20
|
Heidary F, Gharebaghi R | Expert Rev Clin Immunol
Aim: To review the evidence on the antiviral effects of TRIM56.
|
|
|
9/10/20
|
Housing for Health Project | University of Alberta
Aim: To review the evidence on the built environment factors associated with physical activity among older adults during the acute and recovery phases of the COVID-19 and future pandemics.
|
|
|
9/10/20
|
Tricco A | Drug Safety and Effectiveness Network
Aim: To review the evidence on the safety and effectiveness of using fractional dosing strategies to deliver intramuscular seasonal influenza vaccines.
|
|
|
9/10/20
|
Cyr G, Gabet M | Centre de Recherche en Sante Publique
Aim: To review the evidence on the best practices for managing a regional coordination center in a crisis situation.
|
|
|
9/10/20
|
Lester S, Khatwa M, Sutcliffe K | JAMA Intern Med
Aim: To gain a deeper understanding of the kinds of services that young people exposed to ACEs feel they need.
|
|
|
9/10/20
|
Major R, Selvaskandan H, Makkeyah YM, et al. | J Am Soc Nephrol
Aim: To assess the CKD-related inclusion and exclusion criteria for COVID-19 trials.
|
|
|
9/10/20
|
Bornstein S | Newfoundland and Laborador Centre for Applied Health Research
Aim: To review the evidence on the long-term impacts of COVID-19 on infection survivors.
|
|
|
9/3/20
|
Martin A, Blom IM, Whyatt G, et al. | Disaster Med Public Health Prep
Aim: To explore the involvement of medical students in past global health emergencies, to help inform current and future scenarios. UPDATED
|
|
|
9/3/20
|
Sergeant A, van Reekum EA, Sanger N, et al. | BMJ Open
Aim: To study the effect of pandemics and epidemics on mental health outcomes for people with premorbid mental disorders. UPDATED
|
|
|
9/3/20
|
| Health Information and Quality Authority, Ireland
Aim: To review guidance for residential care facilities in the context of COVID-19.
|
|
|
9/3/20
|
| National Collaborating Centre for Methods and Tools
Aim: To review the evidence on the risk of adverse maternal or fetal outcomes in women diagnosed with COVID-19 during pregnancy.
|
|
|
9/3/20
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the volume-outcome relationship for surgical interventions.
|
|
|
9/1/20
|
Gomez-Ochoa SA, Franco OH, Rojas LZ, et al. | Am J Epidemiol
Aim: To systematically review the evidence on the prevalence, risk factors, clinical characteristics, and prognosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among HCW.
|
|
|
9/1/20
|
Leal J, Gagnon H | Alberta Health Services
Aim: To review the evidence on transmission of COVID-19 in condos, apartments, and/or hotels.
|
|
|
9/1/20
|
Gagnon MP | Universite Laval
Aim: To review the evidence on effective digital health interventions to prevent, detect, and manage mental health problems in individuals with a pre-existing chronic diseases.
|
|
|
9/1/20
|
Sharpe H | Alberta Health Services
Aim: To review the evidence on the harm of mask use in specific patient populations.
|
|
|
9/1/20
|
Allison P, de Souza RF, Aboud L, et al. | Public Health Agency of Canada
Aim: To review the evidence on safe dental practices during the COVID-19 pandemic.
|
|
|
9/1/20
|
Clements F | University of Calgary, Health Technology Assessment Unit
Aim: To review the evidence on the immunogenicity and safety of the influenza vaccine at reduced or regular intradermal doses compared with a full intramuscular dose.
|
|
|
9/1/20
|
Smale J | Timiskamig Health Unit
Aim: To review the harms being experienced by community dwelling low income populations from staying at home for long periods of time during current or past pandemics.
|
|
|
9/1/20
|
Erdmann R | Alberta Health Services
Aim: To review the evidence on the risk factors associated with the development of severe outcomes in COVID-19.
|
|
|
9/1/20
|
Carroll A, Hicks A, Saxinger L, et al. | Alberta Health Services
Aim: To review the evidence on the role of children in community SARS-CoV-2 transmission.
|
|
|
8/31/20
|
Juni P, Maltsev A, Bobos P, et al. | Ontario COVID-19 Science Advisory Table
Aim: What is the role of children in SARS-CoV-2 transmission?
|
|
|
8/31/20
|
Centeno-Tablante E, Medina-Rivera M, Finkelstein J, et al. | Ann N Y Acad Sci
Aim: To capture information that might necessitate changes in the guidance on breast milk and breastfeeding given the uncertainty in this area.
|
|
|
8/26/20
|
Kumar D, Loshak H | CADTH
Aim: To compare hand washing with soap and water to hand sanitation solutions, and to review handwashing guidelines for health care workers that come in contact with patients.
|
|
|
8/26/20
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the medium- and long-term health sequelae of COVID-19 infection among survivors.
|
|
|
8/26/20
|
Kotwal A, Yadav A, Kotwal J | Med J Armed Forces India
Aim: To assess correlation between predicted and actual values of cases in India.
|
|
|
8/26/20
|
Nieto I, Navas JF, Vazquez C | Brain Behav Immun Health
Aim: To examine compliance with basic methodological quality criteria and open scientific research practices on the mental health effects of the COVID-19 pandemic.
|
|
|
8/22/20
|
Bayona HHG, Cabaluna ITG, Dans AP, et al. | Asia Pacific Center for Evidence Based Healthcare
Aim: To summarize the available evidence on the diagnostic accurancy of rapid antigen tests for COVID-19.
|
|
|
8/21/20
|
Lechien JR, Radulesco T, Calvo-Henriquez C, et al. | Head Neck Pathol
Aim: To review the data regarding the expression of angiotensin converting enzyme-2 (ACE2) and transmembrane protease serine-2 (TMPRSS2) in head and neck tissue.
|
|
|
8/21/20
|
| Health Information and Quality Authority, Ireland
Aim: To review the evidence on the routine wearing of face masks by healthy persons in the community in reducing the transmission of respiratory pathogens.
|
|
|
8/20/20
|
| Public Health Agency of Canada
Aim: Not provided
|
|
|
8/19/20
|
Selman L, Lapwood S, Jones N, et al. | Oxford COVID-19 Evidence Service
Aim: To review the evidence on advance care planning in community settings during the COVID-19 pandemic.
|
|
|
8/19/20
|
Remillard L, Perras C, Pant S, et al. | CADTH
Aim: To review the current scientific evidence on the potential benefits and harms of chloroquine and hydroxychloroquine for the prevention or treatment of COVID-19.
|
|
|
8/19/20
|
| Public Health Agency of Canada
|
|
|
8/19/20
|
| Public Health Agency of Canada
Aim: To review the evidence on the difference in risk of transmission from persons who are pre- and asymptomatic infected cases compared to symptomatic cases?
|
|
|
8/19/20
|
| Public Health Agency of Canada
Aim: To examine the evidence on whether pregnant women at higher risk of severe COVID-19 disease than non-pregnant women of reproductive age.
|
|
|
8/19/20
|
| Public Health Agency of Canada
Aim: To review the evidence on the impact of physical distancing of 1 meter, 1.5 meters and 2 meters on SARS-CoV-2 virus transmission risk.
|
|
|
8/19/20
|
| Public Health Agency of Canada
|
|
|
8/19/20
|
Kumar D, Spry C | CADTH
Aim: To review the evidence on the effectiveness of face shields at preventing SARS-CoV-2 virus transmission.
|
|
|
8/19/20
|
Guentcheva I | Centre de Recherche en Sante Publique
Aim: To review the effectiveness of the obligation to wear a mask in a population without concrete social acceptability measures having been deployed beforehand.
|
|
|
8/19/20
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the effectiveness of wearing a surgical mask at the same time as an oxygen mask.
|
|
|
8/19/20
|
Topfer L | CADTH
Aim: To identify a list of potential technologies that may be used to address the negative effects of social isolation on older adults living in long-term care.
|
|
|
8/14/20
|
Crisis Standards of Care in the USA: A Systematic Review and Implications for Equity Amidst COVID-19
Manchanda ECC, Sanky C, Appel JM | J Racial Ethn Health Disparities
Aim: To identify and review all publicly available state-level CSC in the USA and to compare the ways in which CSC prioritize patients for the allocation of scarce resources such as ventilators, and to consider the ethical and equity implications of these decisions.
|
|
|
8/12/20
|
Watts T, Choi Y, Odutayo A, et al. | Ontario COVID-19 Science Advisory Table
Aim: To review the evidence on the decrease in antibodies against SARS-CoV-2 over time.
|
|
|
8/12/20
|
Juni P, Odutayo A, Allen U, et al. | Ontario COVID-19 Science Advisory Table
Aim: To review the evidence on the use of dexamethasone in patients hospitalized for COVID-19.
|
|
|
8/11/20
|
Jones L, Candy B, Roberts N, Ondruskova T, et al | Oxford COVID-19 Evidence Service
Aim: To review the evidence on the management of delirium in patients with COVID-19 and the use of non-pharmacological approaches outside of critical care settings. UPDATED
|
|
|
8/11/20
|
Chen C, Pan K, Wu B, et al. | Eur J Clin Pharmacol
Aim: To evaluate the safety of HCQ in the treatment of COVID-19 and other diseases by performing a systematic review and meta-analysis.
|
|
|
8/11/20
|
Licina A, Silvers A, Stuart RL | Syst Rev
Aim: To evaluate the effect of powered air-purifying respirators (PAPRs) as part of respiratory protection versus another device (egN95/FFP2) on HCW infection rates and contamination. UPDATED
|
|
|
8/6/20
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the extended use or re-use of personal protective equipment (PPE) during COVID-19. UPDATED
|
|
|
8/6/20
|
Tariq R, Saha S, Furqan F, et al. | Mayo Clin Proc
Aim: To evaluate the prevalence of gastrointestinal (GI) symptoms and mortality in patients with coronavirus disease 2019 (COVID-19) diagnosed.
|
|
|
8/6/20
|
Agyeman AA, Chin KL, Landersdorfer CB, et al. | Mayo Clin Proc
Aim: To estimate the prevalence of olfactory and gustatory dysfunctions (OGDs) among patients infected with novel coronavirus disease 2019 (COVID-19).
|
|
|
8/5/20
|
Kariyanna PT, Sutarjono B, Grewal E, et al. | Am J Med Case Rep
Aim: To identify the clinical features of myocarditis in COVID-19 patients.
|
|
|
8/5/20
|
Pei L, Zhang S, Huang L, et al. | Pol Arch Intern Med
Aim: To evaluate the impact of drug therapy on the risk of death in patients with COVID-19.
|
|
|
8/5/20
|
| Public Health Agency of Canada
Aim: To review the evidence for age-dependent transmission of SARS-CoV-2.
|
|
|
8/5/20
|
Kumar A, Arora A, Sharma P, et al. | Indian J Gastroenterol
Aim: To determine the frequency of GI and hepatic manifestations of COVID-19 and to explore their relationship with severe clinical course. UPDATED
|
|
|
8/5/20
|
Ghahramani S, Tabrizi R, Lankarani KB, et al. | Eur J Med Res
Aim: To understand the common laboratory features of COVID-19 in severe cases versus non-severe patients could be quite useful for clinicians and might help to predict the model of disease progression. UPDATED
|
|
|
8/5/20
|
Reddy RK, Charles WN, Sklavounos A, et al. | J Med Virol
Aim: To rigorously and definitively quantify the effects of smoking on COVID-19 severity. UPDATED
|
|
|
8/5/20
|
Mansourabadi AH, Sadeghalvad M, Mohammadi-Motlagh H, et al. | Life Sci
Aim: To describe the role of the immune system in response to COVID-19.
|
|
|
8/5/20
|
Desiato VM, Levy DA, Byun YJ, et al. | Am J Rhinol Allergy
Aim: To perform a systematic review and meta-analysis of the prevalence of OD in the healthy general population, review the various assessment metrics used, and compare pooled OD prevalence rates.
|
|
|
8/5/20
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the symptoms and incidence for vascular events in patients with COVID-19.
|
|
|
8/5/20
|
Hasan SS, Radford S, Kow CS, et al. | J Thromb Thrombolysis
Aim: To systematically review the available evidence to help guide clinicians weighing up decisions regarding the anticoagulation approach for COVID-19 patients admitted to intensive care units.
|
|
|
8/4/20
|
Gao Y, Ye L, Zhang J, et al. | BMC Infect Dis
Aim: To systematically review the clinical features and outcomes of pregnant women with COVID-19. UPDATED
|
|
|
8/4/20
|
Yoon SH, Kang J, Ahn JG | Eur Rev Med Pharmacol Sci
Aim: To evaluate the clinical manifestations and outcomes of neonates born to women who had Coronavirus Disease 2019 (COVID-19) during pregnancy.
|
|
|
8/4/20
|
Kay JK, Parsel SM, Marsh JJ, et al. | JAMA Otolaryngol Head Neck Surg
Aim: To review evidence on the risks of aerosolization and transmission of SARS-CoV-2 from patients to health care personnel during endoscopy of the upper aerodigestive tract.
|
|
|
8/4/20
|
Elgohary G | Hematol Oncol Stem Cell Ther
Aim: To evaluate the impact of COVID-19 infection on cancer patients.
|
|
|
8/4/20
|
Khan S, Gionfriddo MR, Cortes-Penfield N, et al. | Expert Opin Pharmacother
Aim: To synthesize the literature on COVID-19 pharmacotherapy to inform practice and policymaking.
|
|
|
8/2/20
|
Sahu AK, Amrithanand VT, Mathew R, et al. | Am J Emerg Med
Aim: To determine the proportion of HCW who were COVID-19 positive among all the COVID-19 patients.
|
|
|
8/2/20
|
Harrop E, Mann M, Semedo L, et al. | Palliat Med
Aim: To synthesise the evidence regarding system-level responses to mass bereavement events, including natural and human-made disasters as well as pandemics, to inform service provision and policy during the COVID-19 pandemic and beyond.
|
|
|
7/31/20
|
| National Collaborating Centre for Methods and Tools
Aim: To review the evidence on how long the virus can survive with potential for infection on surfaces. UPDATED
|
|
|
7/31/20
|
Mitchell S, Maynard V, Lyons V, et al | Palliat Med
Aim: To synthesise existing evidence related to the delivery of palliative and end-of-life care by primary healthcare professionals in epidemics and pandemics. UPDATED
|
|
|
7/30/20
|
Hadeler E, Gitlow H, Nouri K | Arch Dermatol Res
Aim: To evaluate recent studies that have analyzed patient satisfaction with teledermatology.
|
|
|
7/29/20
|
Chakravarti A, Upadhyay S, Bharara T, et al. | Indian J Med Microbiol
Aim: To provide an insight about the current understanding, knowledge gaps and a perspective on the future of coronavirus disease 2019 (COVID-19) infections.
|
|
|
7/29/20
|
Shulte PA, Streit JMK, Sheriff F, et al. | Ann Work Expo Health
Aim: To identify and characterize scenarios and hazards in the future of work after a global pandemic.
|
|
|
7/24/20
|
PHAC Emerging Science Group, Public Health Agency of Canada | Public Health Agency of Canada
Aim: To review the evidence on the effectiveness of face shields at preventing SARS-CoV-2 virus transmission, with and without additional mask wearing.
|
|
|
7/24/20
|
PHAC Emerging Science Group, Public Health Agency of Canada | Public Health Agency of Canada
Aim: To review the evidence on the aerodynamic properties of SARS-CoV-2 virus and travel distance, and the implications on transmission risk.
|
|
|
7/24/20
|
Prevention of heatwaves health impact in general population in time of Covid 19 circulation [French]
| Sante Publique France
|
|
|
7/24/20
|
| Sante Publique France
|
|
|
7/23/20
|
James HK, Pattison GTR | J Surg Educ
Aim: To synthesise the current evidence of pandemic-related impact on surgical training internationally and describe strategies that have been put in place to mitigate disruption.
|
|
|
7/23/20
|
| Public Health Agency of Canada
Aim: To review the evidence on determinants of individual adherence to public health interventions to prevent COVID-19.
|
|
|
7/22/20
|
PHAC Emerging Science Group, Public Health Agency of Canada | Public Health Agency of Canada
Aim: To review the evidence on the de-escelation of "household bubbles" during the COVID-19 pandemic.
|
|
|
7/22/20
|
PHAC Emerging Science Group, Public Health Agency of Canada | Public Health Agency of Canada
Aim: To review the evidence on the thresholds or allowable sizes of gatherings or events during the COVID-19 pandemic.
|
|
|
7/22/20
|
| National Collaborating Centre for Methods and Tools
Aim: To review the evidence on the impact of the COVID-19 pandemic on families with children.
|
|
|
7/22/20
|
Bertrand K, Camire M, Milot D, et al. | University of Sherbrooke
Aim: To review the evidence on gender and sexual diversity in the adaptation of services in the context of the COVID-19 pandemic.
|
|
|
7/20/20
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the risk of adverse post-operative outcomes on patients with COVID-19 or who have previously had COVID-19.
|
|
|
7/20/20
|
Eichberg DG, Basil GW, Di L, et al. | Neurosurgery
Aim: To conduct a systematic literature review investigating treatment of neurosurgical patients via telemedicine, and to evaluate barriers and challenges.
|
|
|
7/18/20
|
Verdugo-Paiva F, Izcovich A, Ragusa M, et al. | Medwave
Aim: To provide a timely, rigorous, and continuously updated summary of the evidence on the role of lopinavir/ritonavir in the treatment of patients with COVID-19. UPDATED
|
|
|
7/17/20
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on whether cardiac stress testing is an aerosol generating procedure and its risk to healthcare workers.
|
|
|
7/17/20
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on post-surgery innovations in an outpatient setting, such as virtual follow up and rehabilitation, in improving outcomes for patients who have undergone surgery.
|
|
|
7/16/20
|
Garg PK, Kaul P, Choudary D, et al. | J Surg Oncol
Aim: To systematically evaluate the available literature on the impact of COVID-19 on cancer care and to critically analyze the diagnostic and therapeutic strategies suggested by various healthcare providers, societies, and institutions.
|
|
|
7/16/20
|
Blair B | Simcoe Muskoka District Health Unit
Aim: To review the evidence on whether staying at home for long periods of time during current or past pandemics worsens the rates of mental and social health outcomes.
|
|
|
7/14/20
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the resumption of elective surgery following cancellation and deferment of routine services during COVID-19.
|
|
|
7/14/20
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on low-value surgery and how to reduce it.
|
|
|
7/14/20
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on post-surgery innovations in hospital such as enhanced recovery, early mobilisation and early discharge in improving outcomes for patients who have undergone surgery?
|
|
|
7/14/20
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on ways to increase productivity or efficiency in operating theatres and managing elective surgery waiting lists?
|
|
|
7/14/20
|
Gavriilidis P, Pai M | J Clin Med Res
Aim: To summarise the existing evidence of impact of COVID-19 global pandemic on liver transplant recipients.
|
|
|
7/10/20
|
| Public Health Agency of Canada
Aim: To review the evidence on the risk of SARS-CoV-2 virus transmission from singing or playing a wood instrument in a choir, orchestra and/or practice setting with other people.
|
|
|
7/10/20
|
Bornstein S | Newfoundland and Laborador Centre for Applied Health Research
Aim: To review the evidence on the impacts of COVID-19 mitigation on non-COVID-19 populations with pre-existing mental health conditions.
|
|
|
7/10/20
|
Lewis J, Mackey K | VA Evidence Synthesis Program
Aim: To critically appraise the identified study and provide additional context for study findings. VA ESP
|
|
|
7/10/20
|
Kernohan A, Calderon M | Oxford COVID-19 Evidence Service
Aim: To review the evidence on risk factors or management of VTE. UPDATED
|
|
|
7/9/20
|
Mackey S, Warren C | Newfoundland and Laborador Centre for Applied Health Research
Aim: To review the evidence on the impacts of COVID-19 mitigation on non-COVID-19 populations with pre-existing substance use and addictions issues.
|
|
|
7/8/20
|
| Sante Publique France
|
|
|
7/8/20
|
Ravani P, Saxinger L, Chandran U, et al. | Alberta Health Services
Aim: To evaluate the current prevalence of COVID-19 infection among asymptomatic patients presenting to Emergency Rooms and requiring hospital admission.
|
|
|
7/8/20
|
| Sante Publique France
|
|
|
7/7/20
|
Lin Y, Duan Q, Zhou Y, et al. | Front Med
Aim: To review existing mathematical and statistical models and build a mathematical model to estimate the transmission capacity, epidemiological characteristics, potential peak time and size, and elimination time of COVID-19.
|
|
|
7/6/20
|
Laperriere H, Bendevis C, et al. | CIHR IRSC
Aim: To review the evidence on how COVID-19 is affecting the mental health of indigenous community members in Ottawa-Gatineau who are living with or affected by HIV or related issues.
|
|
|
7/6/20
|
Kania-Richmond A, Saxinger L, Manns B | Alberta Health Services
Aim: To review the evidence for the effectiveness of remdesivir as a treatment for COVID-19.
|
|
|
7/3/20
|
Spencer EA, Brassey J, Jefferson T, et al. | Oxford COVID-19 Evidence Service
Aim: To explore if climate conditions may influence the spread of SARS-CoV-2. UPDATED
|
|
|
7/3/20
|
Pranata R, Permana H, Huang I, et al. | Diabetes Metab Syndr
Aim: To investigate the association between use of angiotensin-converting enzyme inhibitor (ACEI)/angiotensin-receptor blocker (ARB) and outcomes of hypertensive COVID-19 patients.
|
|
|
7/1/20
|
Greaves L, Brabete AC, Wolfson L, et al. | Centre of Excellence for Women's Health
Aim: To review the evidence on the role of natural disasters and pandemics in intimate partner violence among women and the role of substance use in intimate partner violence among women.
|
|
|
6/30/20
|
Navarro P | Newfoundland and Laborador Centre for Applied Health Research
Aim: To review the evidence on the best practices for personal care workers providing home care in the context of COVID-19.
|
|
|
6/30/20
|
Beesoon S, Jelinski S | Alberta Health Services
Aim: To review the evidence on the risks of infection transmission related to aerosol generation through dental procedures.
|
|
|
6/29/20
|
Dube L, Paquet C, Cisneros-Franco M, et al. | McGill University
Aim: To identify and examine the effectiveness of social connectedness interventions at reducing feelings of social isolation and loneliness and promoting wellbeing, resilience, and coping in the context of infection control-related social and physical distancing measures.
|
|
|
6/26/20
|
Hanrahan JG, Burford C, Adegboyega G, et al. | World Neurosurg
Aim: To detail early experiences and changes to neurosurgical practice in response to the COVID-19 pandemic.
|
|
|
6/26/20
|
Helfand M | VA Evidence Synthesis Program
Aim: To review the evidence for using corticosteroids to treat acute respiratory distress syndrome in patients with COVID-19. VA ESP
|
|
|
6/26/20
|
Duan-Porter W | VA Evidence Synthesis Program
Aim: To explore the length of stay in the intensive care unit (ICU) and time on invasive mechanical ventilation for adult patients with COVID-19. UPDATED VA ESP
|
|
|
6/26/20
|
| Health Information and Quality Authority, Ireland
Aim: To review guidance on physical distancing in non-healthcare settings.
|
|
|
6/25/20
|
| ECRI
Aim: To provide guidance on ways to protect staff, measures to limit transmission, recommendations for COVID-19 testing for pregnant women and for infants born to infected mothers, and optimal maternal care and breastfeeding recommendations.
|
|
|
6/25/20
|
Saleem H, Rahman J, Aslam N, et al. | Cureus
Aim: To review the evidence on COVID-19 severity in children.
|
|
|
6/25/20
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the risk of acquiring COVID-19 on an aircraft.
|
|
|
6/25/20
|
Pelland-St-Pierre L, Duquesne L | Center for Research in Public Health
Aim: To review the evidence on COVID-19 outbreaks in childcare centers and schools, including risk factors, symptoms, and attack rates.
|
|
|
6/25/20
|
Pelland-St-Pierre L, Duquesne L | Centre de Recherche en Sante Publique
Aim: To review the evidence on outbreaks of COVID-19 infection in childcare services and schools across the world.
|
|
|
6/25/20
|
Espinosa OA, Dos Santos Zanetti A, Antunes EF, et al. | Rev Inst Med Trop Sao Paulo
Aim: To calculate the prevalence and geographical distribution of comorbidities in all patients admitted to intensive care units (ICUs), and the mortality rate of COVID-19.
|
|
|
6/25/20
|
Qureshi Z, Jones N, et al. | Oxford COVID-19 Evidence Service
Aim: To identify the evidence behind the 2-metre social distancing rule in the context of the still used large vs. small (droplet vs airborne) droplet size dichotomy in route of transmission. UPDATED
|
|
|
6/24/20
|
Gordon M, Kagalwala T, Rezk K, et al. | BMJ Paediatr Open
Aim: To carry out a systematic review of the available studies on COVID-19 (coronavirus disease 2019) in neonates seen globally since the onset of the COVID-19 global pandemic in 2020.
|
|
|
6/24/20
|
Xu L, Mao Y, Chen G, et al. | Aging
Aim: To systematically review evidence for the risk factors of COVID-19 patients progressing to critical illness.
|
|
|
6/24/20
|
Jones P, Roberts S, Hotu C, et al. | Emerg Med Australas
Aim: To determine the carriage of respiratory viruses on facemasks used by HCW.
|
|
|
6/23/20
|
Gao Y, Liu R, Zhou Q, et al. | Ann Transl Med
Aim: To assess the effectiveness of telemedicine in reducing transmission of COVID-19 and reducing pressure on medical institutions. UPDATED
|
|
|
6/23/20
|
Yang N, Che S, Zhang J, et al. | Ann Transl Med
Aim: To conduct a rapid review of mother-to-child transmission of COVID-19 during breastfeeding. UPDATED
|
|
|
6/23/20
|
Cancer is associated with severe disease in COVID-19 patients: a systematic review and meta-analysis
Ofori-Asenso R, Ogundipe O, Agyeman AA, et al. | Ecancermedicalscience
Aim: To examine the prevalence of cancer and its association with disease severity in patients with novel coronavirus disease 2019 (COVID-19).
|
|
|
6/23/20
|
Gold MS, Sehayek D, Gabrielli S, et al. | Postgrad Med
Aim: To evaluate comorbidities associated with severe and fatal cases of COVID-19.
|
|
|
6/23/20
|
Montesanti S, Silverstone P, Wells L, et al. | CIHR IRSC
Aim: To specifically understand the potential of trauma-focused virtual interventions that can rapidly be used to support domestic violence and sexual assault populations.
|
|
|
6/23/20
|
Zhou Q, Gao Y, Wang X, et al. | Ann Transl Med
Aim: To understand nosocomial infection in patients with COVID-19, SARS, and MERS. UPDATED
|
|
|
6/23/20
|
Thulien N, Noble A, Daley M, et al. | CIHR IRSC
Aim: To review the evidence on promising mental health and substance use practices utilized by front-line providers serving young people who are experiencing or have experienced homelessness during the COVID-19 pandemic.
|
|
|
6/23/20
|
Li W, Liao J, Li Q, et al. | Ann Transl Med
Aim: To review the evidence on how health providers should advise families and parents to obtain health education information during the COVID-19 pandemic.
|
|
|
6/23/20
|
| National Collaborating Centre for Methods and Tools
Aim: To review the evidence on the effect of the COVID-19 pandemic on alcohol use and alcohol-related harms.
|
|
|
6/23/20
|
Prajapat M, Sarma P, Shekhar N, Avti P, Sinha S, Kaur H, Kumar S, Bhattacharyya A, Kumar H, Bansal S, Medhi B | Indian J Pharmacol
Aim: To review the structural basis of different target proteins of SARS-corona virus (CoV2) from a viral life cycle and from drug design perspective.
|
|
|
6/22/20
|
Goodarzi Z, Watt J, Kirkham J, et al | CIHR IRSC
Aim: To review the evidence on the effect of telehealth interventions on depression or depressive symptoms in older adults. UPDATED
|
|
|
6/22/20
|
Best MW, Grossman M, Bowie C, et al. | TIP Research Lab
Aim: To review the evidence on interventions for schizophrenia-spectrum disorders for virtual delivery.
|
|
|
6/22/20
|
Lam R, Murphy J, Michalak E, et al. | CIHR IRSC
Aim: To review the evidence on at-risk groups and their mental health needs in the context of COVID-19 in the Asia Pacific Region and recommendations for improving access to digital mental health support.
|
|
|
6/22/20
|
Lee V, Albaum C, Modica PT, et al. | CMH Initiative
Aim: To better understand what has been documented regarding the impact of the COVID-19 pandemic on caregiver and family functioning, and on mental health services response.
|
|
|
6/22/20
|
Karanasos A, Aznaouridis K, Latsios G, et al. | Nicotine Tob Res
Aim: To summarize relevant studies and quantify the impact of smoking on disease severity and mortality of hospitalized COVID-19 patients.
|
|
|
6/22/20
|
Armitage LC, Brettel R | Oxford COVID-19 Evidence Service
Aim: To review the current evidence on the use of inhaled corticosteroids to prevent the development of acute respiratory distress syndrome.
|
|
|
6/22/20
|
Carroll S, Collins B, Dolce M, et al. | CIHR IRSC
Aim: To review the evidence on how to prevent or mitigate mental health and substance use responses for those at risk of severe COVID-19 infection.
|
|
|
6/22/20
|
Birnie KA, Noel M, Stinson J, et al. | CIHR IRSC
Aim: To review the evidence on virtual care solutions for pain, mental health, and substance use in youth with pre-existing and new onset pain actross the stepped care model during the COVID-19 pandemic.
|
|
|
6/21/20
|
Parohan M, Yaghoubi S, Seraji A | Eur Heart J Acute Cardiovasc Care
Aim: To summarize available findings on the association between cardiac injury and severity of COVID-19 infection.
|
|
|
6/21/20
|
Kunustor SK, Laukkanen JA | J Infect
Aim: To review the evidence on the characteristics and prevalence of hepatic manifestations and complications of COVID-19
|
|
|
6/21/20
|
Ghannam MG, Alshaer QA, Al-Chalabi MAC, et al. | J Neurol
Aim: To clarify the neurological complications of SARS-CoV-2 infection including the potential mechanisms and therapeutic options. UPDATED
|
|
|
6/21/20
|
Montana M, Montero V, Khoumeri O, et al. | Molecules
Aim: To compile and discuss recently published studies concerning the therapeutic potential of the antiviral activity of quinoxaline derivatives.
|
|
|
6/21/20
|
Bienvenu A, Marty AM, Jones MK, et al. | One Health
Aim: To analyze studies registered on ClinicalTrials.gov that study hydroxycholorquine as a COVID-19 prophylaxis.
|
|
|
6/20/20
|
Castro-Rodriguez JA, Forno E | Pediatr Pulmonol
Aim: To review the evidence on the role of asthma in children with COVID-19 and the risk of infection. UPDATED
|
|
|
6/20/20
|
Nobar NN, Goodarzi A | Dermatol Ther
Aim: To review the evidence on the course of COVID-19 in patients with dermatologic disorders, and the most effective management strategies.
|
|
|
6/20/20
|
| Health Technology, Wales
Aim: To reivew the evidence on the use of point-of-care ultrasound imaging for suspected and confirmed cases of COVID-19.
|
|
|
6/20/20
|
Waller JV, Allen IE, Lin KK, et al. | Invest Radiol
Aim: To stratify studies as high or low risk of bias to determine the true sensitivity of CT for severe acute respiratory syndrome coronavirus-2 infection
|
|
|
6/20/20
|
Piscitello GM, Kapania EM, Miller WD, et al. | JAMA Netw Open
Aim: To evaluate the number of publicly available US state guidelines for ventilator allocation and the variation in state recommendations for how ventilator allocation decisions should occur and to assess whether unique criteria exist for pediatric patients.
|
|
|
6/19/20
|
Prato AP, Conforti A, Almstrom M, et al. | Front Pediatr
Aim: To propose technical strategies to assist the pediatric surgeons to minimize the potential aerosolization of viral particles in COVID-19 patients undergoing urgent or emergent surgical treatment using laparoscopic approaches, based on the currently available literature.
|
|
|
6/19/20
|
Althobaiti S, Alharthi S, Moosa A, et al. | Int J Qual Res
Aim: To review the studies on patient perceptions of nursing care quality.
|
|
|
6/19/20
|
Asadi L | Alberta Health Services
Aim: To review the evidence on the effectiveness of wearing medical masks, including home-made masks, to reduce the spread of COVID-19 in the community.
|
|
|
6/19/20
|
Lakhani HV, Pillai SS, Zehra M, et al. | Int J Environ Res Public Health
Aim: To provide insight on the pathogenesis and the transmission dynamics of CoVID-19 along with pharmacological and non-pharmacological intervention strategies to mitigate the clinical manifestation of this virus.
|
|
|
6/19/20
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the impact of COVID-19 on the mode and content of clinical education and current recommendations to address the impact.
|
|
|
6/19/20
|
Gkiouras K, Nigdelis MP, Grammatikopoulou MG, et al. | Eur J Clin Invest
Aim: To assess the availability of open data and metrics and of articles pertaining to the COVID?19 outbreak in five high?impact journals.
|
|
|
6/18/20
|
| Health Information and Quality Authority, Ireland
Aim: To review the evidence on the pathways for the resumption of scheduled hospital-based care postponed or cancelled due to mitigation measures implemented in response to COVID-19.
|
|
|
6/18/20
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the safe use of pools for hydrotherapy or aquatic physiotherapy during COVID-19.
|
|
|
6/18/20
|
Tabari P, Amini M, Moghadami M, et al. | Iran J Med Sci
Aim: To determine countries’ public responses to the epidemic of COVID-19 and how they developed administrative approaches towards the outbreak. UPDATED
|
|
|
6/17/20
|
Grover A, Oberoi M | Eur Heart J Cardiovasc Pharmacother
Aim: To review the evidence on the continued use of angiotensin converting enzyme inhibitors (ACEI) and angtiotensin receptor blockers (ARBs) in patients with COVID-19. UPDATED
|
|
|
6/17/20
|
Agarwal A, Basmaji J, Muttalib F, et al. | Can J Anaesth
Aim: To describe the efficacy and safety of HFNC in acute hypoxemic respiratory failure; and to determine the risk of dispersion, aerosol generation and associated transmission of COVID-19 with HFNC. UPDATED WHO COLLABORATIVE
|
|
|
6/17/20
|
Sharpe H | Alberta Health Services
Aim: To review the evidence on the safety and efficacy of video laryngoscopy in intubating patients with suspected or confirmed COVID-19.
|
|
|
6/17/20
|
Galang RR, Chang K, Strid P, et al. | Obstet Gynecol
Aim: To summarize the clinical presentation, course of illness, and pregnancy and neonatal outcomes in pregnant women with MERS-CoV, SARS-CoV, or SARS-CoV-2.
|
|
|
6/17/20
|
Lauvrak V, Juvet L | Norwegian Institute of Public Health
Aim: To identify any reported associations between increased severity of COVID-19 disease, and infection rates in populations postulated to be socially or economic vulnerable.
|
|
|
6/15/20
|
Pavan N, Crestani A, Abrate A, et al. | Eur Urol Focus
Aim: To evaluate the risk of virus spread due to surgical smoke during surgical procedures.
|
|
|
6/15/20
|
Bornstein S | Newfoundland and Laborador Centre for Applied Health Research
Aim: To review the evidence on the psychological impact of self-isolation on older adults living in the community.
|
|
|
6/14/20
|
Heldwein FL, Loeb S, Wroclawski ML, et al. | Eur Urol Focus
Aim: To summarize guidelines and recommendations on the urology standard of care during the COVID-19 pandemic.
|
|
|
6/14/20
|
Bonilla-Aldana DK, Cardona-Trujillo MC, García-Barco A, et al. | Infez Med
Aim: To review the evidence on the role of animals as potential reservoirs for MERS-CoV and SARS-CoV. UPDATED
|
|
|
6/14/20
|
Samidoust P, Samidoust A, Samadani AA, et al. | Infez Med
Aim: To investigate the incidence of liver injury among published literature from 2019-Jan-01 to 2020-April-03 to provide an outline for further studies on the liver injury of COVID-19.
|
|
|
6/13/20
|
Walker KF, O'Donoghue K, Grace N, et al. | BJOG
Aim: To estimate the risk of the neonate becoming infected with SARS-COV-2 by mode of delivery, type of infant feeding and mother-infant interaction.
|
|
|
6/13/20
|
Patel NA | Am J Otolaryngol
Aim: To elucidate a better understanding of the global impact of COVID-19 on the pediatric population.
|
|
|
6/12/20
|
| Public Health Agency of Canada
Aim: To summarize the literature on associations of ethnicity with risk of infection, severity and mortality to COVID-19.
|
|
|
6/12/20
|
| Public Health Agency of Canada
Aim: To review the evidence on characteristics of the workplace that can increase the risk of COVID-19 transmission.
|
|
|
6/12/20
|
Erdmann R | Alberta Health Services
Aim: To review the evidence on the effectivness of workplace screening programs for reducing the spread of COVID-19 in healthcare settings.
|
|
|
6/12/20
|
| National Collaborating Centre for Methods and Tools
Aim: To identify, appraise, and summarize emerging research evidence on the efficacy and cost-effectiveness of copper materials to reduce transmission of the virus.
|
|
|
6/12/20
|
| National Collaborating Centre for Methods and Tools
Aim: To identify, appraise, and summarize emerging research evidence on the effectiveness of cohorting virus-positive residents to shared rooms in care facilities.
|
|
|
6/12/20
|
Chiesa-Estomba CM, Lechien JR, Calvo-Henriquez C, et al. | Oral Oncol
Aim: To summarize in a systematic way the available recommendations from 18 guidelines from all over the world. UPDATED
|
|
|
6/12/20
|
| Malaysian Health Technology Assessment Section
Aim: To provide scientific evidence on the use of XPEL® RX silver ion protection film for COVID-19 based on a request from the Medical Care Quality Section (MOH) following a proposal from a company to introduce the technology.
|
|
|
6/11/20
|
| Public Health Agency of Canada
Aim: To review the evidence on SARS-CoV-2 transmission in dental settings, and the infection transmission risk from aerosol generating procedures use in dental care?
|
|
|
6/11/20
|
Bresee L, MacDougall D | CADTH
Aim: To describe the epidemiology of venous thromboembolism (VTE), review the evidence on the use of pharmacologic thromboprophylaxis for the prevention of VTE, and list ongoing trials.
|
|
|
6/10/20
|
Bhaumik S, Moola S, Tyagi J, et al. | BMJ Glob Health
Aim: To examine the evidence to inform the potential role, enablers and barriers for community health workers during COVID-19 prevention and control from the National Health Systems Resource Centre (NHSRC), India.
|
|
|
6/10/20
|
| ECRI
Aim: To review the evidence on the optimal timing for performing tracheotomy in patients with acute respiratory failure.
|
|
|
6/10/20
|
Pelland-St-Pierre L, Cortes JB | Center for Research in Public Health
Aim: To review the evidence on the impact of contact time, distance between contacts, and the environment on the probablity of transmission of the coronavirus between humans.
|
|
|
6/10/20
|
Waddell K, Wilson MG, Bullock HL, et al. | McMaster University Health Forum
Aim: To review the evidence on pandemic-related mental health and addictions issues have emerged and what indicators and strategies can be used to monitor and address them.
|
|
|
6/9/20
|
| Health Information and Quality Authority, Ireland
Aim: To review the international evidence on immunity and the spread of the virus by children. UPDATED
|
|
|
6/9/20
|
Ashcroft J, Byrne MHV, Brennan PA, et al. | Postgrad Med J
Aim: To identify pandemic and disaster medicine-themed training programmes aimed at medical students and to assess whether these interventions had an effect on objective measures of disaster preparedness and clinical outcomes.
|
|
|
6/9/20
|
Huntley BJF, Huntley ES, Di Mascio D, et al. | Obstet Gynecol
Aim: To ascertain the frequency of maternal and neonatal complications, as well as maternal disease severity, in pregnancies affected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. UPDATED
|
|
|
6/8/20
|
Carver C, Jones N | Oxford COVID-19 Evidence Service
Aim: To determine if there are any known risk factors for ARDS in this infection and whether there are any interventions to prevent ARDS developing.
|
|
|
6/8/20
|
Parohan M, Yaghoubi S, Seraj A, et al. | Aging Male
Aim: To summarize available findings on the association between age, gender, comorbidities and risk of death from COVID-19 infection. UPDATED
|
|
|
6/8/20
|
Williams S | Newfoundland and Laborador Centre for Applied Health Research
|
|
|
6/7/20
|
Kunutsor S, Laukkanen | J Infect
Aim: To review the evidence on cardiovascular complications associated with COVID-19. UPDATED
|
|
|
6/7/20
|
Dedeilia A, Sotiropoulos MG, Hanrahan JG, et al. | In Vivo
Aim: To identify the challenges imposed on medical and surgical education by the COVID-19 pandemic, and the proposed innovations enabling the continuation of medical student and resident training.
|
|
|
6/6/20
|
Alimohamadi Y, Taghdir M, Sepandi M | J Prev Med Public Health
Aim: To estimate the pooled R0 for COVID-19 in the current outbreak.
|
|
|
6/6/20
|
Quah P, Li A, Phua J | Crit Care
Aim: To review the outcomes of ICU patients with COVID-19 from the existing literature.
|
|
|
6/5/20
|
Lahiri A, Jha SS, Bhattacharya S, et al. | Indian J Public Health
Aim: To understand the effectiveness of NPIs reported in the contemporary literatures describing prediction models for prevention of the ongoing pandemic of SARS-CoV-2 specifically in Indian population.
|
|
|
6/5/20
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the transmission of COVID-19 to and from healthcare professionals and strategies to reduce risk of nosocomial infections of COVID-19.
|
|
|
6/5/20
|
| National Collaborating Centre for Methods and Tools
Aim: To review the evidence on isolation periods other than 14 days in response to COVID-19 in various jurisdictions.
|
|
|
6/5/20
|
Leal J | Alberta Health Services
Aim: To review the evidence on the transmission of SARS-CoV-2 virus through heating, ventiliation, and air conditioning (HVAC) systems in hospitals or non-hospital settings.
|
|
|
6/5/20
|
| National Collaborating Centre for Methods and Tools
Aim: To review the evidence on the duration from expsoure to symptoms or diagnosis for COVID-19.
|
|
|
6/5/20
|
Mackey S, Warren C, Navarro P | Newfoundland and Laborador Centre for Applied Health Research
Aim: To review the approaches being taken to mitigate the risks associated with reopening establishments that provide personal services.
|
|
|
6/5/20
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence regarding temporary workforce reconfigurations such as splitting of teams and establishing social distancing protocols within teams to minimise staff exposure to COVID-19. UPDATED
|
|
|
6/4/20
|
Rosenwohl-Mack A, Schumacher K, Fang ML, et al. | Int J Nurs Stud
Aim: To synthesize the evidence on experiences of aging in place in the United States.
|
|
|
6/4/20
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the use of computed tomography in patients with COVID-19.
|
|
|
6/4/20
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the infection rate, infectivity and transmission of COVID-19 in children?
|
|
|
6/4/20
|
Byambasuren O, Cardona M, Bell K, et al. | medRxiv
Aim: To synthesize all available research on the asymptomatic rates and transmission rates where possible.
|
|
|
6/4/20
|
Pranata R, Lim MA, Huang I, et al. | J Renin Angiotensin Aldosterone Syst
Aim: To investigate the association between hypertension and outcome in patients with Coronavirus Disease 2019 (COVID-19) pneumonia.
|
|
|
6/4/20
|
Abdollahpour S, Khadivzadeh T | J Matern Fetal Neonatal Med
Aim: To improve the quality of care by health providers through what they need to know about coronavirus during pregnancy and childbirth.
|
|
|
6/4/20
|
Smith V, Deo D, Warty R, et al. | PLoS One
Aim: To systematically evaluate the literature and report the maternal and neonatal outcomes associated with COVID-19.
|
|
|
6/4/20
|
Santos VS, Gurgel RQ, Cuevas LE, et al. | J Pediatr Gastroenterol Nutr
Aim: To investigate differences in viral shedding in respiratory and fecal samples from children with COVID-19.
|
|
|
6/4/20
|
Zhang JJY, Lee KS, Ang LW, et al. | Clin Infect Dis
Aim: To review the evidence on predictors of severe disease and the efficacy of different treatments for COVID-19.
|
|
|
6/4/20
|
| Health Technology, Wales
Aim: To review the evidence on the safety of personal protective equipment gowns for health and social care workers.
|
|
|
6/4/20
|
Mitchell S, Maynard V, Lyons V et al. | Oxford COVID-19 Evidence Service
Aim: To review the evidence on the role and response of primary care and community nursing services in the delivery of palliative care in epidemics and pandemics.
|
|
|
6/3/20
|
Yang M, Shang Y, Tian Z, et al. | Integr Med Res
Aim: To review the study characteristics of registered clinical trials on COVID-19 and provide guidance for future trials to avoid duplicated effort.
|
|
|
6/3/20
|
Williams S, Navarro P | Newfoundland and Labrador Centre for Applied Health Research
Aim: To review the evidence on the risk of acquiring COVID-19 associated with singing in a choir?
|
|
|
6/3/20
|
Nacif LS, Zanini LY, Waisberg DR, et al. | Clinics (Sao Paulo)
Aim: To collate available data on COVID-19 infection in solid organ transplantation (SOT) patients.
|
|
|
6/3/20
|
| INESSS Quebec
|
|
|
6/3/20
|
Vestrheim DF, Iversen BG, Flottorp S, et al. | Norwegian Institute of Public Health
Aim: To review the evidence on the use of facemasks by asymptomatic personnel in long-term care facilities for primary prevention of COVID-19 infection.
|
|
|
6/3/20
|
Iannone P, Castellini G, Coclite D, et al. | PLoS One
Aim: To assess the efficacy of N95 respirators versus surgical masks for the prevention of respiratory tract infections transmission among HCWs. UPDATED
|
|
|
6/2/20
|
Raymond M, Ching-A-Sue G, Van Hecke O | Oxford COVID-19 Evidence Service
Aim: To review the evidence on mast cell stabilizers, leukotriene antagonists, and antihistimines in COVID-19. UPDATED
|
|
|
6/2/20
|
Boyd J, Davis A | Alberta Health Services
Aim: To review the various models, scenarios and thresholds that have been used internationally from past pandemics.
|
|
|
6/2/20
|
Liu M, Gao Y, Zhang Y, et al. | J Infect
Aim: To review the evidence on the assocation between severe or death COVID-19 and autoimmune disease.
|
|